The Vanguard Healthcare ETF (VHT) has the following U.S.-listed securities in the list of its holdings:
| No. | Company (Ticker) | Company Description | Stock Price | Market Cap |
|---|---|---|---|---|
| Holdings data may be old. Please check the mentioned 'Update Date' | ||||
| 1) | Johnson and Johnson (JNJ) | Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the health care field worldwide. It operates in three segments: Consumer, Pharma...See Company Profile ...Dividend History ...Candlestick Patterns | $147.59 | $355.66 billion |
| 2) | United Health (UNH) | UnitedHealth Group Incorporated, incorporated on July 1, 2015, is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. The Company conducts its operations ...See Company Profile ...Dividend History ...Candlestick Patterns | $445.63 | $410.84 billion |
| 3) | Merck (MRK) | Merck & Co., Inc., incorporated in 1970, is a global healthcare company. The Company offers health solutions through its prescription medicines, vaccines, biologic therapies and animal health products. It operates ...See Company Profile ...Dividend History ...Candlestick Patterns | $126.19 | $319.64 billion |
| 4) | Pfizer (PFE) | Pfizer Inc. (Pfizer), incorporated on June 2, 1942, is a research-based global biopharmaceutical company. The Company is engaged in the discovery, development and manufacture of healthcare products. Its global portfolio ...See Company Profile ...Dividend History ...Candlestick Patterns | $25.91 | $146.72 billion |
| 5) | Medtronic (MDT) | Medtronic Public Limited Company (Medtronic), incorporated on June 12, 2014, is a medical technology, services and solutions company. The Company operates in four segments: Cardiac and Vascular Group, Minimally Invasive ...See Company Profile ...Dividend History ...Candlestick Patterns | $80.23 | $106.53 billion |
| 6) | Abbott Labs (ABT) | Abbott Laboratories, incorporated on March 6, 1900, is engaged in the discovery, development, manufacture and sale of a range of healthcare products. The Company operates through four segments: Established Pharmaceutical ...See Company Profile ...Dividend History ...Candlestick Patterns | $108.89 | $188.94 billion |
| 7) | Bristol-Myers Squibb (BMY) | Bristol-Myers Squibb Company, incorporated on August 11, 1933, is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceutical products. The Companys pharmaceutical products include chemically synthesized ...See Company Profile ...Dividend History ...Candlestick Patterns | $48.51 | $98.32 billion |
| 8) | Amgen (AMGN) | Amgen Inc., incorporated on October 31, 1986, is a biotechnology company. The Company discovers, develops, manufactures and delivers various human therapeutics. The Company operates in the human therapeutics segment. The ...See Company Profile ...Dividend History | $265.51 | $142.29 billion |
| 9) | Thermo Fisher Scientific (TMO) | Thermo Fisher Scientific Inc., incorporated on October 11, 1960, develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for ...See Company Profile ...Dividend History | $557.87 | $215.76 billion |
| 10) | Eli Lilly (LLY) | Eli Lilly and Company, incorporated on January 17, 1901, is engaged in drug manufacturing business. The Company discovers, develops, manufactures and markets products in two segments: human pharmaceutical products and ...See Company Profile ...Dividend History | $750.77 | $713.81 billion |
| 11) | AbbVie (ABBV) | AbbVie Inc. (AbbVie), incorporated on April 10, 2012, is a research-based biopharmaceutical company. The Company is engaged in the discovery, development, manufacture and sale of a range of pharmaceutical products. ...See Company Profile ...Dividend History ...Candlestick Patterns | $161.67 | $286.26 billion |
| 12) | Danaher (DHR) | Danaher Corporation (Danaher), incorporated on October 3, 1986, designs, manufactures and markets professional, medical, industrial and commercial products and services. As of December 31, 2016, the Companys research and development, ...See Company Profile ...Dividend History ...Candlestick Patterns | $239.66 | $177.69 billion |
| 13) | CVS Health (CVS) | CVS Health Corporation, incorporated on August 22, 1996, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc. ...See Company Profile ...Dividend History ...Candlestick Patterns | $68.96 | $86.92 billion |
| 14) | Gilead Sciences (GILD) | Gilead Sciences, Inc., incorporated on June 22, 1987, is a research-based biopharmaceutical company that discovers, develops and commercializes medicines in areas of unmet medical need. The Companys portfolio of products ...See Company Profile ...Dividend History ...Candlestick Patterns | $67.75 | $84.48 billion |
| 15) | Becton Dickinson and (BDX) | Becton, Dickinson and Company (BD), incorporated in November 1906, is a global medical technology company engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory ...See Company Profile ...Dividend History | $234.72 | $67.94 billion |
| 16) | CIGNA (CI) | Cigna Corporation (Cigna), incorporated on November 3, 1981, together with its subsidiaries, is a health services company. The Company offers medical, dental, disability, life and accident insurance and related products ...See Company Profile ...Dividend History | $348.9 | $99.23 billion |
| 17) | Stryker (SYK) | Stryker Corporation (Stryker), incorporated on February 20, 1946, is a medical technology company. The Company offers a range of medical technologies, including orthopedic, medical and surgical, and neurotechnology and spine ...See Company Profile ...Dividend History | $339.13 | $130.14 billion |
| 18) | Anthem (ANTM) | Anthem, Inc., incorporated on July 17, 2001, is a health benefits company. The Company operates through three segments: Commercial and Specialty Business, Government Business and Other. It offers a full ...See Company Profile ...Dividend History | $482.58 | $116.34 billion |
| 19) | Intuitive Surgical (ISRG) | Intuitive Surgical, Inc. (Intuitive), incorporated on November 9, 1995, designs, manufactures and markets da Vinci Surgical Systems, and related instruments and accessories. The Companys da Vinci Surgical System consists of ...See Company Profile ...Dividend History | $377.36 | $136.39 billion |
| 20) | Zoetis (ZTS) | Zoetis Inc., incorporated on July 25, 2012, is engaged in the discovery, development, manufacture and commercialization of animal health medicines and vaccines, with a focus on both livestock and companion ...See Company Profile ...Dividend History | $149.77 | $68.53 billion |
| 21) | Allergan (AGN) | Allergan plc, incorporated on May 16, 2013, is a specialty pharmaceutical company. The Company is engaged in the development, manufacturing, marketing and distribution of brand name pharmaceutical products, medical aesthetics, ...See Company Profile ...Dividend History | $0 | $0 million |
| 22) | Vertex Pharma (VRTX) | Vertex Pharmaceuticals Incorporated, incorporated on January 4, 1989, is engaged in discovering, developing, manufacturing and commercializing medicines for serious diseases. The Company is focused on developing and commercializing therapies for ...See Company Profile ...Dividend History | $397.36 | $102.7 billion |
| 23) | Boston Scientific (BSX) | Boston Scientific Corporation, incorporated on June 22, 1979, is a developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. The Company offers ...See Company Profile ...Dividend History ...Candlestick Patterns | $67.44 | $100.06 billion |
| 24) | Biogen (BIIB) | Biogen Inc., incorporated on April 1, 1997, is a biopharmaceutical company. The Company focuses on discovering, developing, manufacturing and delivering therapies to people living with serious neurological, rare and autoimmune ...See Company Profile ...Dividend History | $196.8 | $28.81 billion |
| 25) | Edwards Lifesciences (EW) | Edwards Lifesciences Corporation, incorporated on September 10, 1999, is a manufacturer of heart valve systems and repair products used to replace or repair a patients diseased or defective heart valve. ...See Company Profile ...Dividend History | $89.2 | $54.34 billion |
| 26) | Humana (HUM) | Humana Inc. (Humana), incorporated on July 27, 1964, is a health and well-being company. The Companys segments include Retail, Group, Healthcare Services and Other Businesses. The Retail segment consists of ...See Company Profile ...Dividend History | $314.64 | $37.93 billion |
| 27) | Baxter International (BAX) | Baxter International Inc., incorporated on October 19, 1931, through its subsidiaries, provides a portfolio of essential renal and hospital products, including acute and chronic dialysis; sterile intravenous (IV) solutions; infusion ...See Company Profile ...Dividend History | $40.04 | $20.54 billion |
| 28) | Illumina (ILMN) | Illumina, Inc. (Illumina), incorporated on May 16, 2000, is a provider of sequencing- and array-based solutions for genetic analysis. The Company operates through two segments: Core Illumina and the consolidated ...See Company Profile ...Dividend History | $121.16 | $20.24 billion |
| 29) | HCA (HCA) | HCA Holdings, Inc., incorporated on October 19, 2010, is a holding company. The Company, through its subsidiaries, owns and operates hospitals and related healthcare entities. As of December 31, 2016, ...See Company Profile ...Dividend History | $322.63 | $85.38 billion |
| 30) | Centene (CNC) | Centene Corporation, incorporated on September 26, 2001, is a healthcare company. The Company provides a portfolio of services to government sponsored healthcare programs, focusing on under-insured and uninsured individuals. The ...See Company Profile ...Dividend History | $72.72 | $38.9 billion |
| 31) | Zimmer Biomet (ZBH) | Zimmer Biomet Holdings, Inc., incorporated on January 12, 2001, is engaged in designing, manufacturing and marketing of orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; office-based technologies; spine, ...See Company Profile ...Dividend History | $124 | $25.58 billion |
| 32) | Regeneron Pharma (REGN) | Regeneron Pharmaceuticals, Inc., incorporated on January 11, 1988, is a biopharmaceutical company that discovers, invents, develops, manufactures and commercializes medicines for the treatment of serious medical conditions. The Company commercializes ...See Company Profile ...Dividend History | $898.56 | $99.32 billion |
| 33) | McKesson (MCK) | McKesson Corporation (McKesson), incorporated on July 7, 1994, is a pharmaceutical distribution services and information technology company. The Company delivers an offering of pharmaceuticals and medical supplies. The Company operates ...See Company Profile ...Dividend History | $522.68 | $68.73 billion |
| 34) | IQVIA Holdings (IQV) | IQVIA Holdings Inc., formerly Quintiles IMS Holdings, Inc., incorporated on October 3, 2016, provides integrated information and technology-enabled healthcare services. The Company operates through segments, including Commercial Solutions; Research & Development Solutions, and Integrated Engagement Services. | $231.16 | $42.63 billion |
| 35) | Agilent (A) | Agilent Technologies, Inc., incorporated on May 4, 1999, provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, ...See Company Profile ...Dividend History | $140.22 | $41.24 billion |
| 36) | IDEXX Laboratories (IDXX) | IDEXX Laboratories, Inc., incorporated on December 19, 1983, develops, manufactures and distributes products and provides services primarily for the companion animal veterinary, livestock and poultry, dairy and water testing markets. ...See Company Profile ...Dividend History | $491.29 | $41.34 billion |
| 37) | Cerner (CERN) | Cerner Corporation (Cerner), incorporated on October 6, 1986, is a supplier of healthcare information technology (HCIT). The Company offers a range of intelligent solutions and services that support the clinical, ...See Company Profile ...Dividend History | $94.92 | $27.92 billion |
| 38) | ResMed (RMD) | ResMed Inc., incorporated on March 31, 1994, is a holding company. The Company is engaged in the development, manufacturing, distribution and marketing of medical devices and cloud-based software applications that ...See Company Profile ...Dividend History | $185.09 | $27.34 billion |
| 39) | Alexion Pharma (ALXN) | Alexion Pharmaceuticals, Inc., incorporated on January 28, 1992, is a biopharmaceutical company. The Company is focused on the development and commercialization of therapeutic products. The Companys products include Soliris (eculizumab), ...See Company Profile ...Dividend History | $182.5 | $40.34 billion |
| 40) | DexCom (DXCM) | Dexcom, Inc. (Dexcom), incorporated on May 13, 1999, is a medical device company. The Company is focused on the design, development and commercialization of continuous glucose monitoring systems for ambulatory ...See Company Profile ...Dividend History | $134.56 | $52.49 billion |
| 41) | Align Technology (ALGN) | Align Technology, Inc., incorporated on April 3, 1997, designs, manufactures and markets a system of clear aligner therapy, intra-oral scanners and computer-aided design/computer-aided manufacturing (CAD/CAM) digital services used in dentistry, ...See Company Profile ...Dividend History | $304.74 | $23.7 billion |
| 42) | Veeva (VEEV) | Veeva Systems Inc. provides cloud-based software for the life sciences industry in North America, Europe, the Asia Pacific, and internationally. The company offers Veeva Commercial Cloud, a suite of m...See Company Profile ...Dividend History | $201.62 | $33.35 billion |
| 43) | Mettler Toledo (MTD) | Mettler-Toledo International Inc., incorporated on December 6, 1991, is a supplier of precision instruments and services. The Company operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese ...See Company Profile ...Dividend History | $1243.56 | $26.97 billion |
| 44) | Cooper Companies (COO) | The Cooper Companies, Inc., incorporated on March 4, 1980, is a global medical device company. The Company operates through two business units: CooperVision, Inc. and CooperSurgical, Inc. CooperVision offers soft ...See Company Profile ...Dividend History | $92.04 | $18.59 billion |
| 45) | Teleflex (TFX) | Teleflex Incorporated, incorporated on June 25, 1943, is a provider of medical technology products. The Company primarily designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare ...See Company Profile ...Dividend History | $210.66 | $9.92 billion |
| 46) | Laboratory of America (LH) | Laboratory Corporation of America Holdings, incorporated on March 8, 1994, is a life sciences company that is integrated in guiding patient care, providing clinical laboratory and end-to-end drug development services. ...See Company Profile ...Dividend History | $203.32 | $17.31 billion |
| 47) | Cardinal Health (CAH) | Cardinal Health, Inc. is a healthcare services and products company. The Company operates through two segments: Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, over-the-counter ...See Company Profile ...Dividend History | $107.03 | $26.03 billion |
| 48) | BioMarin Pharmaceutical (BMRN) | BioMarin Pharmaceutical Inc., incorporated on October 25, 1996, is a biotechnology company. The Company develops and commercializes pharmaceuticals for various diseases and medical conditions. As of December 31, 2016, the ...See Company Profile ...Dividend History | $91.51 | $17.51 billion |
| 49) | Waters Corp. (WAT) | Waters Corporation, incorporated on December 6, 1991, is an analytical instrument manufacturer. The Company operates through two segments: Waters and TA. The Company designs, manufactures, sells and services high performance ...See Company Profile ...Dividend History | $319.59 | $19.14 billion |
| 50) | Quest Diagnostics (DGX) | Quest Diagnostics Incorporated, incorporated on September 20, 1996, is a provider of diagnostic information services. The Company operates through two businesses: Diagnostic Information Services and Diagnostic Solutions. The Diagnostic Information ...See Company Profile ...Dividend History | $128.64 | $14.29 billion |
| 51) | Hologic (HOLX) | Hologic, Inc., incorporated on January 18, 1990, is a developer, manufacturer and supplier of diagnostics products, medical imaging systems and surgical products with an emphasis on womens health. The Company ...See Company Profile ...Dividend History | $77.54 | $18.2 billion |
| 52) | Exact Sciences (EXAS) | Exact Sciences Corporation, incorporated on February 10, 1995, is a molecular diagnostics company. The Company focuses on the early detection and prevention of some forms of cancer. The Company offers ...See Company Profile ...Dividend History | $65.35 | $11.86 billion |
| 53) | AmerisourceBergen (ABC) | AmerisourceBergen Corporation, incorporated on March 16, 2001, is a pharmaceutical sourcing and distribution services company. The Companys segments include Pharmaceutical Distribution and Other. The Company provides services to healthcare providers, ...See Company Profile ...Dividend History | $179.98 | $36.15 billion |
| 54) | Incyte (INCY) | Incyte Corporation, incorporated on April 8, 1991, is a biopharmaceutical company. The Company is focused on the discovery, development and commercialization of therapeutics. The Companys portfolio includes compounds in various ...See Company Profile ...Dividend History | $53.43 | $12.1 billion |
| 55) | Seattle Genetics (SGEN) | Seattle Genetics, Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company markets ADCETRIS, an antibody-d...See Company Profile ...Dividend History | $212.72 | $40.13 billion |
| 56) | Varian Medical (VAR) | Varian Medical Systems, Inc., incorporated on January 22, 1976, is a manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and ...See Company Profile ...Dividend History | $177.07 | $16.26 billion |
| 57) | Alnylam Pharma (ALNY) | Alnylam Pharmaceuticals, Inc., incorporated on May 8, 2003, is a biopharmaceutical company. The Company is engaged in the discovery, development and commercialization of ribonucleic acid (RNA) interference (RNAi) therapeutics. The ...See Company Profile ...Dividend History | $147.7 | $18.78 billion |
| 58) | STERIS (STE) | STERIS plc provides infection prevention and other procedural products and services. The Company operates through four segments: Healthcare Products, which offers infection prevention and procedural solutions for healthcare providers, including ...See Company Profile ...Dividend History | $201.21 | $20.16 billion |
| 59) | Dentsply Sirona (XRAY) | DENTSPLY SIRONA Inc., incorporated on February 15, 1983, is a manufacturer of professional dental products and technologies. The Company develops, manufactures, and markets solutions offering, including dental and oral health ...See Company Profile ...Dividend History | $30.89 | $6.5 billion |
| 60) | Elanco Animal Health (ELAN) | Elanco Animal Health Incorporated, an animal health company, develops, manufactures, and markets products for companion and food animals in the United States and internationally. It offers companion animal dise...See Company Profile ...Dividend History | $13.87 | $7.07 billion |
| 61) | Insulet (PODD) | Insulet Corporation, incorporated on July 20, 2000, is engaged in the development, manufacturing and sale of the OmniPod Insulin Management System (the OmniPod System), an insulin delivery system for people ...See Company Profile ...Dividend History | $173.94 | $12.27 billion |
| 62) | West Pharmaceutical (WST) | West Pharmaceutical Services, Inc., incorporated on July 27, 1923, is a manufacturer of packaging components and delivery systems for injectable drugs and healthcare products. The Companys products include vial containment ...See Company Profile ...Dividend History | $378.81 | $27.82 billion |
| 63) | Mylan (MYL) | Mylan N.V., incorporated on July 7, 2014, is a global pharmaceutical company. The Company develops, licenses, manufactures, markets and distributes generic, brand name and over-the-counter (OTC) products in a range ...See Company Profile ...Dividend History | $0 | $0 million |
| 64) | Universal Health (UHS) | Universal Health Services, Inc., incorporated on January 8, 1979, is a holding company. The Companys principal business is owning and operating, through its subsidiaries, acute care hospitals and outpatient facilities, ...See Company Profile ...Dividend History | $166.42 | $11.23 billion |
| 65) | PerkinElmer (PKI) | PerkinElmer, Inc., incorporated on November 13, 1947, is a provider of products, services and solutions to the diagnostics, research, environmental, industrial and laboratory services markets. The Company operates through two ...See Company Profile ...Dividend History | $115.24 | $14.46 billion |
| 66) | Henry Schein (HSIC) | Henry Schein, Inc., incorporated on December 23, 1992, is a provider of healthcare products and services primarily to office-based dental, animal health and medical practitioners. The Company operates through two ...See Company Profile ...Dividend History | $70.73 | $9.12 billion |
| 67) | Catalent (CTLT) | Catalent, Inc., incorporated on March 14, 2007, is a provider of delivery technologies and development solutions for drugs, biologics, and consumer and animal health products. The Companys segments include Softgel ...See Company Profile ...Dividend History | $56.08 | $10.18 billion |
| 68) | Neurocrine Biosciences (NBIX) | Neurocrine Biosciences, Inc., incorporated on March 20, 1996, is engaged in discovering and developing pharmaceuticals, in diseases with unmet medical needs, through its research and development (R&D) platform, focused on ...See Company Profile ...Dividend History | $131.74 | $13.54 billion |
| 69) | Sarepta Therapeutics (SRPT) | Sarepta Therapeutics, Inc., incorporated on June 5, 2013, is a biopharmaceutical company. The Company focuses on the discovery and development of ribose nucleic acid (RNA)-targeted therapeutics for the treatment of ...See Company Profile ...Dividend History | $118.31 | $11.54 billion |
| 70) | Masimo (MASI) | Masimo Corporation, incorporated on May 7, 1996, is a medical technology company that develops, manufactures and markets a range of non-invasive patient monitoring technologies. The Companys business is Measure-through Motion ...See Company Profile ...Dividend History | $138.11 | $7.31 billion |
| 71) | ABIOMED (ABMD) | ABIOMED, Inc., incorporated on June 4, 1987, is a provider of temporary percutaneous mechanical circulatory support devices. The Company offers care to heart failure patients. The Company operates in the ...See Company Profile ...Dividend History | $381.02 | $17.18 billion |
| 72) | DaVita (DVA) | DaVita Inc., formerly DaVita HealthCare Partners Inc., incorporated on April 4, 1994, operates two divisions: DaVita Kidney Care (Kidney Care) and DaVita Medical Group (DMG). The Kidney Care division consists ...See Company Profile ...Dividend History | $129.96 | $11.39 billion |
| 73) | Jazz Pharma (JAZZ) | Jazz Pharmaceuticals Public Limited Company, incorporated on March 15, 2005, is a biopharmaceutical company. The Company is focused on developing and commercializing products that address unmet medical needs. The Company ...See Company Profile ...Dividend History | $110.91 | $6.92 billion |
| 74) | Bio-Rad Laboratories (BIO) | Bio-Rad Laboratories, Inc. (Bio-Rad), incorporated on March 10, 1975, is a manufacturer and distributor of its life science research and clinical diagnostics products. The Company operates through two segments: Life ...See Company Profile ...Dividend History | $300.41 | $8.76 billion |
| 75) | Bio-Techne (TECH) | Bio-Techne Corporation, incorporated on July 17, 1981, develops, manufactures and sells biotechnology reagents and instruments for the research and clinical diagnostic markets. The Company operates through three segments: Biotechnology, Clinical ...See Company Profile ...Dividend History | $65.52 | $10.3 billion |
| 76) | Ionis Pharma (IONS) | Ionis Pharmaceuticals, Inc., incorporated on March 25, 1991, is engaged in discovering and developing ribonucleic acid (RNA)-targeted therapeutics. The Company, using its drug discovery platform, has developed a pipeline of ...See Company Profile ...Dividend History | $41.55 | $6.08 billion |
| 77) | Encompass Health (EHC) | Encompass Health Corporation provides facility-based and home-based post-acute healthcare services in the United States. The company operates through two segments, Inpatient Rehabilitation, and Home Health and ...See Company Profile ...Dividend History | $80.73 | $8.08 billion |
| 78) | Charles River Laboratories International (CRL) | Charles River Laboratories International, Inc., incorporated on February 3, 1994, is an early-stage contract research company. The Company is engaged in laboratory animal medicine and science (research model technologies) and ...See Company Profile ...Dividend History | $235.93 | $12.43 billion |
| 79) | Perrigo (PRGO) | Perrigo Company plc (Perrigo), formerly Perrigo Company Limited, incorporated on June 28, 2013, is an over-the-counter (OTC) consumer goods and specialty pharmaceutical company. The Companys segments include Consumer Healthcare (CHC), ...See Company Profile ...Dividend History | $30.13 | $4.11 billion |
| 80) | Chemed (CHE) | Chemed Corporation, incorporated on April 2, 1970, purchases, operates and divests subsidiaries engaged in various business activities. The Company operates through two segments: the VITAS segment (VITAS) and the Roto-Rooter ...See Company Profile ...Dividend History | $615.89 | $9.36 billion |
| 81) | Molina Healthcare (MOH) | Molina Healthcare, Inc., incorporated on July 24, 2002, offers Medicaid-related solutions for low-income families and individuals, and assists government agencies in their administration of the Medicaid program. The Company operates ...See Company Profile ...Dividend History | $360.85 | $21.14 billion |
| 82) | Hill-Rom (HRC) | Hill-Rom Holdings, Inc., incorporated on August 7, 1969, is a global medical technology company. The Company partners with healthcare providers by focusing on patient care solutions that improve clinical and ...See Company Profile ...Dividend History | $155.96 | $10.3 billion |
| 83) | Teladoc (TDOC) | Teladoc, Inc. is a telehealth company. The Company offers telehealth platform, delivering on-demand healthcare anytime, anywhere, through mobile devices, the Internet, video and phone. The Companys solution connects its Members, ...See Company Profile ...Dividend History | $13.55 | $2.41 billion |
| 84) | Horizon Pharma (HZNP) | Horizon Pharma Public Limited Company, a biopharmaceutical company, focuses on researching, developing, and commercializing medicines that address unmet treatment needs for rare and rheumatic diseases...See Company Profile ...Dividend History | $115.93 | $26.55 billion |
| 85) | PRA Health Sciences (PRAH) | PRA Health Sciences, Inc., incorporated on June 21, 2013, is a contract research organization (CRO). The Company provides outsourced clinical development services to the biotechnology and pharmaceutical industries. The Company ...See Company Profile ...Dividend History | $165.21 | $10.71 billion |
| 86) | Amedisys (AMED) | Amedisys, Inc., together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and Personal Care. The Home Health segment ...See Company Profile ...Dividend History | $91.35 | $2.98 billion |
| 87) | Penumbra (PEN) | Penumbra, Inc., incorporated on June 21, 2004, is a healthcare company focused on interventional therapies. The Company designs, develops, manufactures and markets medical devices. The Company has a portfolio of ...See Company Profile ...Dividend History | $210.19 | $8.14 billion |
| 88) | Haemonetics (HAE) | Haemonetics Corporation (Haemonetics), incorporated on August 29, 1985, is a healthcare company. The Company provides various products to customers involved in the processing, handling and analysis of blood. The Companys ...See Company Profile ...Dividend History | $84.88 | $4.31 billion |
| 89) | Bruker (BRKR) | Bruker Corporation, incorporated on February 4, 2000, is a developer, manufacturer and distributor of scientific instruments and analytical and diagnostic solutions that enable its customers to explore life and materials ...See Company Profile ...Dividend History | $85.75 | $12.05 billion |
| 90) | Exelixis (EXEL) | Exelixis, Inc., incorporated on November 15, 1994, is a biopharmaceutical company. The Company is focused on discovery, development and commercialization of new medicines to manage care and outcomes for people ...See Company Profile ...Dividend History | $22.7 | $6.92 billion |
| 91) | HealthEquity (HQY) | HealthEquity, Inc., incorporated on October 18, 2002, is a provider of a range of solutions for managing healthcare accounts (Health Savings Accounts (HSAs), Health Reimbursement Arrangements (HRAs) and Flexible Spending ...See Company Profile ...Dividend History | $80.23 | $6.91 billion |
| 92) | Repligen (RGEN) | Repligen Corporation, incorporated on May 29, 1981, is a bioprocessing company. The Company is focused on the development, manufacture and commercialization of products used to improve the interconnected phases of ...See Company Profile ...Dividend History | $166.39 | $9.29 billion |
| 93) | bluebird bio (BLUE) | bluebird bio, Inc., incorporated on April 16, 1992, is a clinical-stage biotechnology company. The Company is focused on developing gene therapies for severe diseases and cancer. With its lentiviral-based gene ...See Company Profile ...Dividend History | $1.03 | $213.91 million |
| 94) | United Therapeutics (UTHR) | United Therapeutics Corporation, incorporated on June 26, 1996, is a biotechnology company. The Company is focused on the development and commercialization of products for the treatment of chronic and life-threatening ...See Company Profile ...Dividend History | $235.08 | $11.06 billion |
| 95) | LHC (LHCG) | LHC Group, Inc., incorporated on January 20, 2005, is a holding company. The Company provides post-acute healthcare services to patients through its home nursing agencies, hospice agencies, community-based services agencies ...See Company Profile ...Dividend History | $169.81 | $5.29 billion |
| 96) | ACADIA Pharma (ACAD) | ACADIA Pharmaceuticals Inc., incorporated on January 16, 1997, is a biopharmaceutical company. The Company is focused on the development and commercialization of medicines for central nervous system (CNS) disorders. The ...See Company Profile ...Dividend History | $16.89 | $2.82 billion |
| 97) | Reata Pharma (RETA) | Reata Pharmaceuticals, Inc., incorporated on March 11, 2002, is a clinical-stage biopharmaceutical company. The Company is focused on identifying, developing and commercializing product candidates that modulate the activity of regulatory ...See Company Profile ...Dividend History | $172.36 | $6.57 billion |
| 98) | Avantor (AVTR) | Avantor, Inc. develops, customizes, manufactures, and supplies products and services to customers in the biopharma, healthcare, education and government, and advanced technologies and applied materials industries. The company's materials and consumables include ultra-high purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-us...See Company Profile ...Dividend History | $24.71 | $16.78 billion |
| 99) | Nevro (NVRO) | Nevro Corp., a medical device company, provides products for the patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal...See Company Profile ...Dividend History | $12.49 | $481.54 million |
| 100) | Acceleron Pharma (XLRN) | Acceleron Pharma Inc., incorporated on June 13, 2003, is a clinical-stage biopharmaceutical company. The Company is focused on the discovery, development and commercialization of therapeutics to treat serious and rare ...See Company Profile ...Dividend History | $178.75 | $10.93 billion |
| 101) | Globus Medical (GMED) | Globus Medical, Inc., a medical device company, focuses on the design, development, and commercialization of musculoskeletal implants that promote healing in patients with spine disorders. The company...See Company Profile ...Dividend History | $51.82 | $7.02 billion |
| 102) | NuVasive (NUVA) | Nuvasive, Inc., incorporated on July 21, 1997, is a medical device company. The Company focuses on developing minimally-disruptive surgical products and procedurally-integrated solutions for the spine surgery. The Companys product ...See Company Profile ...Dividend History | $39.75 | $2.09 billion |
| 103) | Tandem Diabetes Care (TNDM) | Tandem Diabetes Care, Inc., incorporated on January 7, 2008, is a medical device company. The Company is engaged in designing, developing and commercializing products for people with insulin-dependent diabetes. The ...See Company Profile ...Dividend History | $31.86 | $2.16 billion |
| 104) | Integra LifeSciences (IART) | Integra LifeSciences Holdings Corporation, incorporated on June 19, 1989, is a medical technology company. The Company focuses on the development, manufacturing, and marketing of surgical implants and medical instruments. The ...See Company Profile ...Dividend History | $32.06 | $2.58 billion |
| 105) | Global Blood Therapeutics (GBT) | Global Blood Therapeutics, Inc., incorporated on February 04, 2011, is a clinical-stage biopharmaceutical company. The Company is engaged in discovering, developing and commercializing therapeutics to treat blood-based disorders. The Company ...See Company Profile ...Dividend History | $68.49 | $4.62 billion |
| 106) | Syneos Health (SYNH) | Syneos Health, Inc. operates as an integrated biopharmaceutical solutions company in North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates through two segments, Clinic...See Company Profile ...Dividend History | $42.98 | $4.46 billion |
| 107) | Wright Medical (WMGI) | Wright Medical Group N.V. is a medical device company. The Company is focused on extremities and biologics products. The Companys segments include U.S. Lower Extremities & Biologics, U.S. Upper Extremities ...See Company Profile ...Dividend History | $0 | $0 million |
| 108) | ICU Medical (ICUI) | ICU Medical, Inc., incorporated on January 9, 1992, is engaged in the development, manufacture and sales of medical devices used in infusion therapy, oncology and critical care applications. The Companys ...See Company Profile ...Dividend History | $97.1 | $2.4 billion |
| 109) | Arrowhead Pharma (ARWR) | Arrowhead Pharmaceuticals, Inc., formerly Arrowhead Research Corporation, incorporated on February 13, 2001, develops medicines that treat intractable diseases by silencing the genes that cause them. Using a portfolio of ribonucleic ...See Company Profile ...Dividend History | $24.01 | $3.06 billion |
| 110) | Nektar Therapeutics (NKTR) | Nektar Therapeutics, incorporated on June 3, 1998, is a biopharmaceutical company that discovers and develops medicines in areas of high unmet medical need. The Companys research and development pipeline of ...See Company Profile ...Dividend History | $1.57 | $306.64 million |
| 111) | Envista (NVST) | Envista Holdings Corporation manufactures and sells dental products in the United States and internationally. The company's Specialty Products & Technologies segment provides dental implant systems, guided surgery systems, biomaterials, prefabricated and custom-built prosthetics, and dental eye loupes to oral surgeons, prosthodontists, and periodontists under the brands, including Nobel Biocare, Alpha ...See Company Profile ...Dividend History | $19.14 | $3.3 billion |
| 112) | Neogen (NEOG) | Neogen Corporation, incorporated on June 30, 1981, develops, manufactures and markets a range of products and services dedicated to food and animal safety. The Company operates through two segments: Food ...See Company Profile ...Dividend History | $12.01 | $2.6 billion |
| 113) | Sage Therapeutics (SAGE) | SAGE Therapeutics, Inc., incorporated on April 16, 2010, is a clinical-stage biopharmaceutical company. The Company is engaged in developing and commercializing medicines to treat central nervous system (CNS) disorders. The ...See Company Profile ...Dividend History | $15.32 | $920.84 million |
| 114) | Omnicell (OMCL) | Omnicell, Inc. (Omnicell), incorporated on April 14, 2000, is a provider of automation and business analytics software solutions for patient-centric medication and supply management across the entire healthcare continuum, from ...See Company Profile ...Dividend History | $26.88 | $1.23 billion |
| 115) | LivaNova (LIVN) | LivaNova PLC is a medical device company focused on the development and delivery of therapeutic solutions. The Companys segments include Cardiac Surgery, Cardiac Rhythm Management, Neuromodulation and Other. The Cardiac ...See Company Profile ...Dividend History | $53.37 | $2.88 billion |
| 116) | FibroGen (FGEN) | FibroGen, Inc., incorporated on September 29, 1993, is a science-based biopharmaceutical company. The Company is engaged in the discovery, development and commercialization of therapeutics to treat serious unmet medical needs. ...See Company Profile ...Dividend History | $1.31 | $129.39 million |
| 117) | Momenta Pharma (MNTA) | Momenta Pharmaceuticals, Inc., incorporated on May 17, 2001, is a biotechnology company. The Company is focused on developing generic versions of drugs, biosimilars and therapeutics for oncology and autoimmune disease. ...See Company Profile ...Dividend History | $0 | $0 million |
| 118) | NeoGenomics (NEO) | NeoGenomics, Inc., incorporated on October 29, 1998, is an operator of a network of cancer-focused genetic testing laboratories. The Company operates in Laboratory Testing Segment. This segment delivers testing services ...See Company Profile ...Dividend History | $13.75 | $1.76 billion |
| 119) | AMN Healthcare (AMN) | AMN Healthcare Services, Inc., incorporated on November 10, 1997, provides healthcare workforce solutions and staffing services at acute and sub-acute care hospitals and other healthcare facilities throughout the United States. ...See Company Profile ...Dividend History | $57.09 | $2.16 billion |
| 120) | Agios Pharma (AGIO) | Agios Pharmaceuticals, Inc., incorporated on August 7, 2007, is a clinical-stage biopharmaceutical company. The Companys therapeutic areas of focus are cancer and rare genetic metabolic disorders, which are a group ...See Company Profile ...Dividend History | $29.26 | $1.66 billion |
| 121) | MyoKardia (MYOK) | MyoKardia, Inc., incorporated on June 8, 2012, is a clinical-stage biopharmaceutical company. The Company focuses on the treatment of heritable cardiomyopathies, a group of rare, genetically-driven forms of heart failure ...See Company Profile ...Dividend History | $0 | $0 million |
| 122) | Blueprint Medicines (BPMC) | Blueprint Medicines Corporation, incorporated on October 14, 2008, is a biopharmaceutical company. The Company focuses on patients with genomically defined diseases driven by abnormal kinase activation. The Company focuses on ...See Company Profile ...Dividend History | $85.18 | $5.34 billion |
| 123) | Acadia Healthcare (ACHC) | Acadia Healthcare Company, Inc. develops and operates inpatient psychiatric facilities, residential treatment centers, group homes, substance abuse facilities, and outpatient behavioral healthcare fac...See Company Profile ...Dividend History | $73.11 | $6.76 billion |
| 124) | Ultragenyx Pharmaceutical (RARE) | Ultragenyx Pharmaceutical Inc., incorporated on June 13, 2011, is a clinical-stage biopharmaceutical company. The Company is focused on the identification, acquisition, development, and commercialization of products for the treatment of ...See Company Profile ...Dividend History | $42.87 | $3.87 billion |
| 125) | Immunomedics (IMMU) | Immunomedics, Inc., incorporated on July 6, 1982, is a clinical-stage biopharmaceutical company, which is engaged in researching, developing, manufacturing and marketing biopharmaceutical products. It develops monoclonal antibody-based products for the ...See Company Profile ...Dividend History | $0 | $0 million |
| 126) | CONMED (CNMD) | CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for minimally invasive procedures in the Americas, Europe, the Middle East, A...See Company Profile ...Dividend History | $75.23 | $2.32 billion |
| 127) | Quidel (QDEL) | Quidel Corporation, incorporated on July 14, 1987, is engaged in the development, manufacturing and marketing of diagnostic testing solutions. These diagnostic testing solutions are separated into four product categories: immunoassays, ...See Company Profile ...Dividend History | $41.45 | $2.82 billion |
| 128) | Guardant Health (GH) | Guardant Health, Inc., a precision oncology company, provides non-invasive cancer diagnostics. It offers liquid biopsy tests for advanced stage cancer, such as Guardant360, a molecular diagnostic test that meas...See Company Profile ...Dividend History | $17.06 | $2.22 billion |
| 129) | Integer (ITGR) | Integer Holdings Corporation, formerly Greatbatch, Inc., incorporated on June 13, 1997, is a medical device outsource manufacturing company. The Companys segments include Medical and Non-Medical. It serves the cardiac, neuromodulation, ...See Company Profile ...Dividend History | $118.65 | $3.98 billion |
| 130) | Tenet Healthcare (THC) | Tenet Healthcare Corporation (Tenet), incorporated on November 7, 1975, is a healthcare services company. The Company operates regionally focused, integrated healthcare delivery networks in large urban and suburban markets in ...See Company Profile ...Dividend History | $99.4 | $9.86 billion |
| 131) | PTC Therapeutics (PTCT) | PTC Therapeutics, Inc., incorporated on March 31, 1998, is a biopharmaceutical company. The Company is focused on the discovery, development and commercialization of medicines using its expertise in ribonucleic acid ...See Company Profile ...Dividend History | $25.68 | $1.97 billion |
| 132) | Select Medical (SEM) | Select Medical Holdings Corporation, incorporated on October 14, 2004, is an operator of specialty hospitals, outpatient rehabilitation clinics and occupational medicine centers in the United States. The Companys segments include ...See Company Profile ...Dividend History | $27.59 | $3.54 billion |
| 133) | Halozyme Therapeutics (HALO) | Halozyme Therapeutics, Inc., incorporated on August 23, 2007, is a biotechnology company focused on developing and commercializing oncology therapies. The Company operates in research, development and commercialization of human enzymes ...See Company Profile ...Dividend History | $38.72 | $4.92 billion |
| 134) | Mirati Therapeutics (MRTX) | Mirati Therapeutics, Inc., incorporated on April 29, 2013, is a clinical-stage biopharmaceutical company. The Company is focused on developing a pipeline of targeted oncology products. The Companys clinical pipeline consists ...See Company Profile ...Dividend History | $58.7 | $4.12 billion |
| 135) | Cantel Medical (CMD) | Cantel Medical Corp., incorporated on August 16, 1963, is a provider of infection prevention products and services in the healthcare market. The Companys operating segments include Endoscopy; Water Purification and ...See Company Profile ...Dividend History | $80.37 | $3.4 billion |
| 136) | Medpace (MEDP) | Medpace Holdings, Inc., incorporated on February 18, 2014, is a clinical contract research organization. The Company provides clinical research-based drug and medical device development services. The Company partners with pharmaceutical, ...See Company Profile ...Dividend History | $387.14 | $12.24 billion |
| 137) | Emergent Biosolutions (EBS) | Emergent BioSolutions Inc., incorporated on December 19, 2003, is a life sciences company. The Company focuses on protecting and enhancing life by providing specialty products for civilian and military populations ...See Company Profile ...Dividend History | $1.98 | $107.54 million |
| 138) | Intercept Pharma (ICPT) | Intercept Pharmaceuticals, Inc., incorporated on September 4, 2002, is a biopharmaceutical company. The Company is focused on the development and commercialization of therapeutics to treat non-viral, progressive liver diseases. The ...See Company Profile ...Dividend History | $18.96 | $792.68 million |
| 139) | Apellis Pharmaceuticals (APLS) | Apellis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapeutic compounds for autoimmune and inflammatory diseases. Its lead product candidate is APL-2...See Company Profile ...Dividend History | $51.5 | $6.24 billion |
| 140) | HMS (HMSY) | HMS Holdings Corp., incorporated on October 4, 2002, is a holding company. The Company, through its subsidiaries, operates in the United States healthcare insurance benefit cost containment marketplace. The Company ...See Company Profile ...Dividend History | $36.97 | $3.29 billion |
| 141) | Arena Pharma (ARNA) | Arena Pharmaceuticals, Inc., incorporated on April 14, 1997, is a biopharmaceutical company. The Company is focused on developing small molecule drugs across a range of therapeutic areas. The Company has ...See Company Profile ...Dividend History | $99.99 | $6.17 billion |
| 142) | Amicus Therapeutics (FOLD) | Amicus Therapeutics, Inc., incorporated on February 4, 2002, is a biotechnology company. The Company is engaged in the discovery, development and commercialization of a set of treatments for patients living ...See Company Profile ...Dividend History | $10.66 | $3.16 billion |
| 143) | The Ensign (ENSG) | The Ensign Group, Inc., incorporated on May 27, 1999, through its operating subsidiaries, provides healthcare services across the post-acute care continuum, as well as other ancillary businesses located in Arizona, ...See Company Profile ...Dividend History | $118.69 | $6.75 billion |
| 144) | Iovance Biotherapeutics (IOVA) | Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate canc...See Company Profile ...Dividend History | $11.89 | $3.45 billion |
| 145) | Glaukos (GKOS) | Glaukos Corporation, incorporated on July 14, 1998, is an ophthalmic medical technology company. The Company focuses on the development and commercialization of products and procedures for the treatment of glaucoma. ...See Company Profile ...Dividend History | $96.84 | $4.86 billion |
| 146) | Premier (PINC) | Premier, Inc., incorporated on May 14, 2013, is a healthcare improvement company. The Company is uniting an alliance of approximately 3,750 United States hospitals and more than 130,000 other provider ...See Company Profile ...Dividend History | $20.75 | $2.49 billion |
| 147) | iRhythm (IRTC) | iRhythm Technologies, Inc. is a United States-based digital health company. The Company develops and commercializes solutions that integrate biosensor technology, patient data, analytics and medical expertise. The Company offers flagship ...See Company Profile ...Dividend History | $109.48 | $3.52 billion |
| 148) | Biohaven Pharmaceutical Holding Company (BHVN) | Biohaven Pharmaceutical Holding Company Ltd., a clinical-stage biopharmaceutical company, develops product candidates to treat neurological diseases, including rare disorders. Its lead product candidate is rime...See Company Profile ...Dividend History | $44.77 | $4.34 billion |
| 149) | Mednax (MD) | MEDNAX, Inc., incorporated on October 10, 2007, is a provider of physician services, including newborn, anesthesia, maternal-fetal, teleradiology, pediatric cardiology and other pediatric subspecialty care. As of December 31, 2016, ...See Company Profile ...Dividend History | $9.17 | $770.52 million |
| 150) | Axsome Therapeutics (AXSM) | Axsome Therapeutics, Inc., incorporated on January 12, 2012, is a clinical-stage biopharmaceutical company. The Company is engaged in developing therapies for the management of central nervous system (CNS) disorders, including ...See Company Profile ...Dividend History | $68.21 | $3.27 billion |
| 151) | Zogenix (ZGNX) | Zogenix, Inc., incorporated on May 11, 2006, is a pharmaceutical company engaged in developing and commercializing central nervous system (CNS) therapies that address specific clinical needs for people living with ...See Company Profile ...Dividend History | $26.68 | $1.5 billion |
| 152) | Myriad Genetics (MYGN) | Myriad Genetics, Inc. (Myriad), incorporated on November 6, 1992, is a molecular diagnostic company. The Company is engaged in the discovery, development and marketing of transformative molecular diagnostic tests. The ...See Company Profile ...Dividend History | $19.17 | $1.76 billion |
| 153) | Merit Medical (MMSI) | Merit Medical Systems, Inc., incorporated on July 28, 1987, is a manufacturer and marketer of disposable medical devices used in a range of interventional, diagnostic and therapeutic medical procedures. The ...See Company Profile ...Dividend History | $71.96 | $4.18 billion |
| 154) | Prestige Brand (PBH) | Prestige Brands Holdings, Inc., incorporated on June 24, 2004, is engaged in the marketing, sales and distribution of over-the-counter healthcare and household cleaning products to mass merchandisers, drug stores, supermarkets, ...See Company Profile ...Dividend History | $68.14 | $3.38 billion |
| 155) | Alkermes (ALKS) | Alkermes plc, incorporated on May 4, 2011, is a biopharmaceutical company. The Company is engaged in the researching, developing and commercializing pharmaceutical products that are designed to address medical needs ...See Company Profile ...Dividend History | $24.02 | $4.01 billion |
| 156) | Patterson Companies (PDCO) | Patterson Companies, Inc., incorporated on June 15, 1992, is a distributor serving the dental, veterinary and rehabilitation supply markets. The Company operates through three segments: dental supply, veterinary supply and ...See Company Profile ...Dividend History | $25.35 | $2.28 billion |
| 157) | Ironwood Pharma (IRWD) | Ironwood Pharmaceuticals, Inc., incorporated on January 5, 1998, is a biotechnology company. The Company is advancing product opportunities in areas of unmet need, including irritable bowel syndrome with constipation (IBS ...See Company Profile ...Dividend History | $7.79 | $1.23 billion |
| 158) | Insmed (INSM) | Insmed Incorporated, incorporated on March 21, 2013, is a biopharmaceutical company. The Company operates through development and commercialization of therapies for patients with rare diseases segment. The Companys lead product ...See Company Profile ...Dividend History | $26.82 | $4.05 billion |
| 159) | Heron Therapeutics (HRTX) | Heron Therapeutics, Inc., incorporated on February 5, 1987, is a biotechnology company. The Company is engaged in developing pharmaceutical products for patients suffering from cancer or pain. The Companys product ...See Company Profile ...Dividend History | $2.95 | $443.47 million |
| 160) | Xencor (XNCR) | Xencor, Inc., incorporated on June 8, 2004, is a clinical-stage biopharmaceutical company. The Company is focused on discovering and developing engineered monoclonal antibodies to treat severe and life threatening diseases. ...See Company Profile ...Dividend History | $20.11 | $1.25 billion |
| 161) | Allakos (ALLK) | Allakos Inc., a clinical stage biopharmaceutical company, focuses on developing therapeutic antibodies targeting allergic, inflammatory, and proliferative diseases. The company is developing AK002 for the treat...See Company Profile ...Dividend History | $1.08 | $97.63 million |
| 162) | Ligand Pharma (LGND) | Ligand Pharmaceuticals Incorporated (Ligand), incorporated on September 28, 1987, is a biopharmaceutical company that focuses on developing and acquiring technologies that help pharmaceutical companies discover and develop medicines. The Company ...See Company Profile ...Dividend History | $79.77 | $1.44 billion |
| 163) | BioTelemetry (BEAT) | BioTelemetry, Inc., incorporated on April 12, 2013, provides monitoring services and digital population health management in a healthcare setting, medical device manufacturing and centralized laboratory services for clinical research. The ...See Company Profile ...Dividend History | $1.84 | $51.34 million |
| 164) | Magellan Health (MGLN) | Magellan Health, Inc., incorporated on August 11, 1969, is engaged in the healthcare management business. The Companys segments include Healthcare, Pharmacy Management and Corporate. The Company is focused on managing ...See Company Profile ...Dividend History | $94.99 | $2.5 billion |
| 165) | Invitae (NVTA) | Invitae Corporation, incorporated on January 13, 2010, utilizes an integrated portfolio of laboratory processes, software tools and informatics capabilities to process deoxyribonucleic acid (DNA)-containing samples, analyze information about patient-specific genetic ...See Company Profile ...Dividend History | $0.39 | $111.56 million |
| 166) | Natera (NTRA) | Natera, Inc., incorporated on January 26, 2007, is a diagnostics company. The Company is engaged in the discovery, development and commercialization of genetic testing services. The Company operates a laboratory ...See Company Profile ...Dividend History | $90.42 | $11.41 billion |
| 167) | Pacira Pharma (PCRX) | Pacira Pharmaceuticals, Inc., incorporated on December 22, 2006, is a holding company. The Company is a pharmaceutical company focused on the development, manufacture and commercialization of pharmaceutical products, based on ...See Company Profile ...Dividend History | $26.53 | $1.23 billion |
| 168) | Cardiovascular (CSII) | Cardiovascular Systems, Inc., incorporated on December 6, 2000, is a medical technology company. The Company is engaged in treating patients suffering from peripheral and coronary artery diseases, including those with ...See Company Profile ...Dividend History | $19.88 | $838.9 million |
| 169) | ChemoCentryx (CCXI) | ChemoCentryx, Inc., incorporated on November 8, 1996, is a biopharmaceutical company. The Company is engaged in developing new medications targeted at inflammatory disorders, autoimmune diseases and cancer. Each of the ...See Company Profile ...Dividend History | $51.99 | $3.74 billion |
| 170) | Kodiak Sciences (KOD) | Kodiak Sciences Inc., a clinical stage biopharmaceutical company, provides novel therapeutics to treat ophthalmic diseases. The company's lead product candidate is KSI-301, a vascular endothelial growth factor ...See Company Profile ...Dividend History | $3.87 | $232.16 million |
| 171) | AtriCure (ATRC) | AtriCure, Inc., incorporated on October 31, 2000, is an atrial fibrillation (Afib) solutions company. The Company develops, manufactures, and sells devices designed primarily for the surgical ablation of cardiac tissue ...See Company Profile ...Dividend History | $22.9 | $1.11 billion |
| 172) | Allscripts Healthcare (MDRX) | Allscripts Healthcare Solutions, Inc. (Allscripts), incorporated on July 11, 2000, delivers information technology (IT) solutions and services to help healthcare organizations. The Company operates through three segments: Clinical and Financial ...See Company Profile ...Dividend History | $8.27 | $903.58 million |
| 173) | Deciphera Pharmaceuticals (DCPH) | Deciphera Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durabi...See Company Profile ...Dividend History | $14.9 | $1.22 billion |
| 174) | Fate Therapeutics (FATE) | Fate Therapeutics, Inc. (Fate Therapeutics), incorporated on April 27, 2007, is a clinical-stage biopharmaceutical company. The Company is engaged in development of programmed cellular immunotherapies for cancer and immune disorders. ...See Company Profile ...Dividend History | $5.64 | $641.74 million |
| 175) | Epizyme (EPZM) | Epizyme, Inc., incorporated on November 1, 2007, is a clinical-stage biopharmaceutical company. The Company discovers, develops and plans to commercialize epigenetic therapies for cancer patients. The Company is engaged in ...See Company Profile ...Dividend History | $1.47 | $247.5 million |
| 176) | US Physical Therapy (USPH) | U.S. Physical Therapy, Inc., incorporated on April 1, 1992, through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative ...See Company Profile ...Dividend History | $101.01 | $1.55 billion |
| 177) | REGENXBIO (RGNX) | REGENXBIO Inc., incorporated on July 16, 2008, is a clinical-stage biotechnology company. The Companys gene therapy product candidates are designed to deliver genes to cells to address genetic defects or ...See Company Profile ...Dividend History | $18.02 | $883.75 million |
| 178) | Denali Therapeutics (DNLI) | Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. The company offers leucine-rich repeat kinase 2 (LRRK2) ...See Company Profile ...Dividend History | $17.84 | $2.54 billion |
| 179) | Ra Pharma (RARX) | Ra Pharmaceuticals, Inc. is a United States-based clinical-stage biopharmaceutical company. The Company focuses on the development of therapeutics for diseases of complement dysregulation and a range of orphan indications. It ...See Company Profile ...Dividend History | $0 | $0 million |
| 180) | Avanos Medical (AVNS) | Avanos Medical, Inc. operates as a medical technology company that focuses on eliminating pain, speeding recovery, and preventing infection for healthcare providers and patients worldwide. Its Medical Devices s...See Company Profile ...Dividend History | $18.85 | $870.95 million |
| 181) | Inovalon (INOV) | Inovalon Holdings, Inc., incorporated on September 11, 2014, is a technology company. The Company combines cloud-based data analytics and data-driven intervention platforms to provide services for health plans, hospitals, physicians, ...See Company Profile ...Dividend History | $41.06 | $6.37 billion |
| 182) | Esperion Therapeutics (ESPR) | Esperion Therapeutics, Inc., incorporated on January 22, 2008, is a lipid management company. The Company is a late-stage pharmaceutical company focused on developing and commercializing once-daily, oral therapies for the ...See Company Profile ...Dividend History | $1.94 | $396.01 million |
| 183) | Intra-Cellular Therapies (ITCI) | Intra-Cellular Therapies, Inc. (ITI), incorporated on August 29, 2012, is a biopharmaceutical company. The Company is focused on the discovery and clinical development of small molecule drugs that address underserved ...See Company Profile ...Dividend History | $64.76 | $6.38 billion |
| 184) | Supernus Pharma (SUPN) | Supernus Pharmaceuticals, Inc., incorporated on March 30, 2005, is a pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases. The Company offers ...See Company Profile ...Dividend History | $29.99 | $1.66 billion |
| 185) | Addus HomeCare (ADUS) | Addus HomeCare Corporation, incorporated on July 27, 2006, is a provider of personal care services, which are provided primarily in the home. The Companys personal care services include assistance with ...See Company Profile ...Dividend History | $96.73 | $1.57 billion |
| 186) | Corcept Therapeutics (CORT) | Corcept Therapeutics Incorporated, incorporated on May 13, 1998, is a pharmaceutical company engaged in the discovery, development and commercialization of drugs for the treatment of severe metabolic, psychiatric and oncologic ...See Company Profile ...Dividend History | $23.15 | $2.44 billion |
| 187) | Theravance Biopharma (TBPH) | Theravance Biopharma, Inc. (Theravance Biopharma) is a biopharmaceutical company. The Company is engaged in creating medicines for patients suffering from serious illness. The Company operates in the segment of discovery ...See Company Profile ...Dividend History | $9.92 | $481.72 million |
| 188) | TG Therapeutics (TGTX) | TG Therapeutics, Inc. (TG), incorporated on May 18, 1993, is a biopharmaceutical company focused on the acquisition, development and commercialization of treatments for B-cell malignancies and autoimmune diseases. As of ...See Company Profile ...Dividend History | $14.07 | $2.18 billion |
| 189) | Veracyte (VCYT) | Veracyte, Inc., incorporated on August 15, 2006, is a genomic diagnostics company. The Company uses genomic technology to resolve diagnostic ambiguity. The Company targets diseases in which patients undergo invasive ...See Company Profile ...Dividend History | $19.37 | $1.45 billion |
| 190) | Editas Medicine (EDIT) | Editas Medicine, Inc., incorporated on September 3, 2013, is a genome editing company. The Company is engaged in treating patients with genetically defined diseases by correcting their disease-causing genes. The ...See Company Profile ...Dividend History | $6.08 | $508.07 million |
| 191) | Aimmune Therapeutics (AIMT) | Aimmune Therapeutics, Inc., incorporated on June 24, 2011, is a clinical-stage biopharmaceutical company developing a therapeutic approach, including the development of product candidates, for the treatment of peanut and other ...See Company Profile ...Dividend History | $0 | $0 million |
| 192) | Principia Biopharma (PRNB) | Principia Biopharma Inc., a clinical-stage biopharmaceutical company, focuses on developing novel oral therapies for immunology and oncology in the United States. It is developing PRN1008, an inhibitor that is ...See Company Profile ...Dividend History | $0 | $0 million |
| 193) | CryoLife (CRY) | CryoLife, Inc. (CryoLife), incorporated on January 19, 1984, is a medical device manufacturer and processor, and is engaged in the distribution of medical devices and implantable human tissues used in ...See Company Profile ...Dividend History | $17.88 | $703.21 million |
| 194) | R1 RCM (RCM) | R1 RCM Inc. provides revenue cycle management (RCM) for healthcare providers in the United States. It offers end-to-end RCM services to manage their revenue cycle operations, which encompass patient registration, insurance and benefit verification, medical treatment documentation and coding, and bill preparation and collection from patients and payers. The company ...See Company Profile ...Dividend History | $12.33 | $5.24 billion |
| 195) | STAAR Surgical (STAA) | STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and delivery systems to deliver the lenses into the eye. The...See Company Profile ...Dividend History | $46.22 | $2.26 billion |
| 196) | Tabula Rasa HealthCare (TRHC) | Tabula Rasa HealthCare, Inc. (Tabula Rasa), formerly CareKinesis, Inc., is a provider of patient-specific, data-driven technology and solutions that enable healthcare organizations to optimize medication regimens to improve patient outcomes, ...See Company Profile ...Dividend History | $10.41 | $281.6 million |
| 197) | Varex Imaging (VREX) | Varex Imaging Corporation designs and manufactures X-ray imaging components. The company operates in two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components comprising X-ray tubes, digital detectors, high voltage connectors, image-processing software and workstations, computer-aided diagnostic software, collimators, automatic exposur...See Company Profile ...Dividend History | $17.4 | $706.76 million |
| 198) | Atrion (ATRI) | Atrion Corporation (Atrion), incorporated on December 30, 1996, is engaged in developing and manufacturing products, primarily for medical applications. The Companys medical products range from fluid delivery devices to ophthalmic ...See Company Profile ...Dividend History | $398.68 | $701.61 million |
| 199) | Natus Medical Incorporated (NTUS) | Natus Medical Incorporated provides medical device solutions focusing on the diagnosis and treatment of patients with central nervous and sensory system...See Company Profile | $32.96 | $1.14 billion |
| 200) | Tivity Health (TVTY) | Tivity Health, Inc., formerly Healthways, Inc., incorporated on September 2, 1981, is focused targeted population health for those aged 50 and older. The Company offers three programs: SilverSneakers senior fitness, ...See Company Profile ...Dividend History | $32.5 | $1.62 billion |
| 201) | Revance Therapeutics (RVNC) | Revance Therapeutics, Inc., incorporated on August 10, 1999, is a clinical-stage biotechnology company. The Company is focused on the development, manufacturing and commercialization of botulinum toxin products for multiple aesthetic ...See Company Profile ...Dividend History | $3.97 | $413.74 million |
| 202) | Turning Point Therapeutics (TPTX) | Turning Point Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in designing and developing novel small molecule targeted oncology therapies. It develops a pipeline of tyrosine kinase inhibitors (TKIs) that targets genetic drivers of cancer and TKI-pretreated patients. The company's lead drug candidate repotrectinib (TPX-0005) is being evaluated in an ongoing Phase...See Company Profile ...Dividend History | $76.01 | $3.81 billion |
| 203) | Forty Seven (FTSV) | Forty Seven Inc., a clinical-stage immuno-oncology company, focuses on developing therapies to activate macrophages for the treatment of cancer. It is developing 5F9, a humanized IgG4 subclass monoclonal antibo...See Company Profile ...Dividend History | $0 | $0 million |
| 204) | Mesa Laboratories (MLAB) | Mesa Laboratories, Inc., incorporated on March 26, 1982, is focused primarily on quality control products and services. The Company operates through four segments: Instruments, Continuous Monitoring, Biological Indicators and Cold ...See Company Profile ...Dividend History | $104.45 | $563.41 million |
| 205) | Innoviva (INVA) | Innoviva, Inc., formerly Theravance, Inc., incorporated on November 19, 1996, focuses on bringing new medicines to patients in areas of unmet need. The Company is engaged in the development, commercialization ...See Company Profile ...Dividend History | $14.4 | $925.65 million |
| 206) | Dicerna Pharma (DRNA) | Dicerna Pharmaceuticals, Inc., incorporated on October 24, 2006, is a ribonucleic acid (RNA) interference-based biopharmaceutical company. The Company operates in the segment of discovery, research and development of treatments based ...See Company Profile ...Dividend History | $38.22 | $2.98 billion |
| 207) | Portola Pharma (PTLA) | Portola Pharmaceuticals, Inc., incorporated on September 2, 2003, is a biopharmaceutical company. The Company is focused on the development and commercialization of therapeutics in the areas of thrombosis, other hematologic ...See Company Profile ...Dividend History | $0 | $0 million |
| 208) | Luminex (LMNX) | Luminex Corporation, incorporated on June 19, 1998, develops, manufactures and sells biological testing technologies with applications throughout the diagnostics, pharmaceutical and life sciences industries. The Companys products are focused on ...See Company Profile ...Dividend History | $36.99 | $1.75 billion |
| 209) | Tactile Technology (TCMD) | Tactile Systems Technology, Inc., a medical technology company, develops and provides medical devices for the treatment of chronic diseases in the United States. The company offers proprietary Flexito...See Company Profile ...Dividend History | $14.1 | $350.92 million |
| 210) | National HealthCare (NHC) | National HealthCare Corporation (NHC), incorporated on September 26, 1997, is principally engaged in the operation of skilled nursing facilities, assisted living facilities, independent living facilities and homecare programs. The Company ...See Company Profile ...Dividend History | $87.97 | $1.37 billion |
| 211) | RadNet (RDNT) | RadNet, Inc., incorporated on June 19, 2008, is a provider of freestanding, fixed-site outpatient diagnostic imaging services in the United States. As of December 31, 2016, the Company operated directly ...See Company Profile ...Dividend History | $47.81 | $3.52 billion |
| 212) | CareDx (CDNA) | CareDx, Inc., incorporated on December 21, 1998, is a molecular diagnostics company. The Company is focused on the discovery, development and commercialization of clinically differentiated diagnostic surveillance solutions for transplant ...See Company Profile ...Dividend History | $8.2 | $440.64 million |
| 213) | Aerie Pharma (AERI) | Aerie Pharmaceuticals, Inc., incorporated on June 22, 2005, is a clinical-stage pharmaceutical company. The Company is engaged in the discovery, development and commercialization of therapies for the treatment of patients ...See Company Profile ...Dividend History | $15.25 | $753.62 million |
| 214) | CorVel (CRVL) | CorVel Corporation (Corvel), incorporated on May 16, 1991, is a provider of workers compensation solutions for employers, third party administrators, insurance companies and government agencies. The Company offers its services ...See Company Profile ...Dividend History | $238.49 | $4.08 billion |
| 215) | Coherus BioSciences (CHRS) | Coherus BioSciences, Inc., incorporated on September 29, 2010, is a late-stage clinical biologics platform company. The Company is engaged in the business of developing and commercializing biosimilar products. The Companys ...See Company Profile ...Dividend History | $2.2 | $247.97 million |
| 216) | Arvinas Holding Co (ARVN) | Arvinas Holding Company, LLC, a biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead products include ARV-110, prote...See Company Profile ...Dividend History | $34.72 | $2.47 billion |
| 217) | Covetrus (CVET) | Covetrus, Inc., together with its subsidiaries, operates as an animal-health technology and services company. It engages in the sale of animal-health...See Company Profile ...Dividend History | $20.99 | $2.94 billion |
| 218) | Inspire Medical Systems (INSP) | Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire s...See Company Profile ...Dividend History | $223.14 | $7.02 billion |
| 219) | Codexis (CDXS) | Codexis, Inc., incorporated on January 31, 2002, is a developer of biocatalysts for the pharmaceutical and fine chemicals markets. The Companys technologies enable scale-up and implementation of biocatalytic solutions for ...See Company Profile ...Dividend History | $2.69 | $202.47 million |
| 220) | Sangamo Therapeutics (SGMO) | Sangamo Therapeutics, Inc., formerly Sangamo BioSciences, Inc., incorporated on June 22, 1995, is a clinical-stage biotechnology company. The Company is focused on translating science into genomic therapies that transform patients ...See Company Profile ...Dividend History | $0.56 | $113.06 million |
| 221) | Dermira (DERM) | Dermira, Inc., incorporated on August 18, 2010, is a biopharmaceutical company. As of December 31, 2016, the Companys portfolio included three late-stage product candidates that target unmet needs and market ...See Company Profile ...Dividend History | $4.02 | $88.54 million |
| 222) | Inogen (INGN) | Inogen, Inc., incorporated on November 27, 2001, is a medical technology company. The Company develops, manufactures and markets portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients ...See Company Profile ...Dividend History | $7.16 | $167.02 million |
| 223) | Intersect ENT (XENT) | Intersect ENT, Inc., incorporated on October 6, 2003, is a commercial-stage drug-device company. The Company develops drugs for patients with ear, nose and throat (ENT) conditions. The Company has developed ...See Company Profile ...Dividend History | $28.24 | $954.9 million |
| 224) | Endo International (ENDP) | Endo International plc, incorporated on October 31, 2013, is a generics and specialty branded pharmaceutical company. The Company operates through three segments: U.S. Generic Pharmaceuticals, U.S. Branded Pharmaceuticals and International ...See Company Profile ...Dividend History | $0.29 | $68.8 million |
| 225) | Orthofix International (OFIX) | Orthofix International N.V. (Orthofix), incorporated on October 19, 1987, is a global medical device company. The Company is focused on providing reconstructive and regenerative orthopedic and spine solutions to physicians. ...See Company Profile ...Dividend History | $13.09 | $498.64 million |
| 226) | Silk Road Medical (SILK) | Silk Road Medical, Inc. operates as a medical device company in the United States. It offers ENROUTE Transcarotid Neuroprotection System that is used to directly access the common carotid artery and initiate temporary blood flow reversal; ENROUTE Transcarotid Stent System, a self-expanding, self-tapering stent with clinical data regarding lasting safety outcomes; ENHANCE Transcarotid Peripheral Access ...See Company Profile ...Dividend History | $18.05 | $712.59 million |
| 227) | National Research (NRC) | National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience in the United States and Canada. Its portfolio of subscription-ba...See Company Profile ...Dividend History | $34.22 | $816.88 million |
| 228) | Enanta Pharma (ENTA) | Enanta Pharmaceuticals, Inc., incorporated on July 25, 1995, is a research and development-focused biotechnology company. The Company uses chemistry-driven approach and drug discovery solutions to create small molecule drugs for ...See Company Profile ...Dividend History | $16.15 | $348.02 million |
| 229) | ImmunoGen (IMGN) | ImmunoGen, Inc., incorporated on March 27, 1981, is a clinical-stage biotechnology company that develops targeted cancer therapeutics using its antibody-drug conjugate (ADC) technology. The Company is engaged in the discovery ...See Company Profile ...Dividend History | $29.26 | $8.17 billion |
| 230) | Hanger, Inc. (HNGR) | Hanger, Inc. provides orthotic and prosthetic (O&P) services; and distributes O&P devices and components, manages O&P networks, and provides therapeutic...See Company Profile | $18.72 | $732.39 million |
| 231) | The Providence Service (PRSC) | The Providence Service Corporation (Providence), incorporated on December 20, 1996, is a holding company. The Company, through its subsidiaries, is engaged in the provision of healthcare and workforce development services ...See Company Profile ...Dividend History | $155.58 | $2.21 billion |
| 232) | Karyopharm Therapeutics (KPTI) | Karyopharm Therapeutics Inc., incorporated on December 22, 2008, is a clinical-stage pharmaceutical company. The Company is focused on the discovery, development and commercialization of drugs directed against nuclear transport and ...See Company Profile ...Dividend History | $1.16 | $140.76 million |
| 233) | Evolent Health (EVH) | Evolent Health, Inc., incorporated December 12, 2014, is engaged in healthcare delivery and payment. The Company supports health systems and physician organizations in their migration toward value-based care and population ...See Company Profile ...Dividend History | $30.3 | $3.45 billion |
| 234) | Radius Health (RDUS) | Radius Health, Inc., incorporated on February 4, 2008, is a biopharmaceutical company. The Company is focused on the developing therapeutics in the areas of osteoporosis, oncology and endocrine diseases. The ...See Company Profile ...Dividend History | $17.6 | $492.49 million |
| 235) | Change Healthcare (CHNG) | Change Healthcare Inc., an independent healthcare technology platform, provides data and analytics-driven solutions to improve clinical, financial, and patient engagement outcomes in the United States healthcare system. It operates in three segments: Software and Analytics, Network Solutions, and Technology-Enabled Services. The Software and Analytics segment provides software and analytics solutions f...See Company Profile ...Dividend History | $27.49 | $9.03 billion |
| 236) | Amphastar Pharma (AMPH) | Amphastar Pharmaceuticals, Inc., incorporated on May 19, 2004, is a specialty pharmaceutical company. The Company focuses primarily on developing, manufacturing, marketing and selling generic and injectable, inhalation and intranasal products. ...See Company Profile ...Dividend History | $40.78 | $1.99 billion |
| 237) | Heska (HSKA) | Heska Corporation, incorporated on March 27, 1997, sells veterinary diagnostic and specialty products. The Company operates through two segments: Core Companion Animal Health (CCA) and Other Vaccines, Pharmaceuticals and Products ...See Company Profile ...Dividend History | $119.84 | $1.31 billion |
| 238) | Atara Biotherapeutics (ATRA) | Atara Biotherapeutics, Inc., incorporated on August 22, 2012, is a clinical-stage biopharmaceutical company. The Company is focused on developing therapies for patients with severe and life-threatening diseases. The Company operates ...See Company Profile ...Dividend History | $0.68 | $83.46 million |
| 239) | Lantheus (LNTH) | Lantheus Holdings, Inc., incorporated on November 30, 2007, is engaged in the development, manufacture and commercialization of diagnostic medical imaging agents and products that assist clinicians in the diagnosis and ...See Company Profile ...Dividend History | $60.25 | $4.17 billion |
| 240) | Vocera Communications (VCRA) | Vocera Communications, Inc., incorporated on February 16, 2000, is a provider of communication solutions for mobile workers in healthcare, hospitality, energy, education and other industries. The Companys segments include Product ...See Company Profile ...Dividend History | $79.13 | $2.77 billion |
| 241) | Tricida (TCDA) | Tricida, Inc. operates as a pharmaceutical company. It focuses on the development and commercialization of TRC101, a non-absorbed orally-administered polymer drug that has completed Phase III clinical trials to...See Company Profile ...Dividend History | $0.11 | $6.27 million |
| 242) | Cara Therapeutics (CARA) | Cara Therapeutics, Inc., incorporated on July 2, 2004, is a clinical-stage biopharmaceutical company. The Company is focused on developing and commercializing chemical entities designed to alleviate pain and pruritus by ...See Company Profile ...Dividend History | $0.71 | $41.1 million |
| 243) | Vericel (VCEL) | Vericel Corporation (Vericel), formerly Aastrom Biosciences, Inc., incorporated on March 24, 1989, is a commercial-stage biopharmaceutical company dedicated to the identification, development and commercialization of therapies that enable the body ...See Company Profile ...Dividend History | $48.7 | $2.36 billion |
| 244) | Rocket Pharmaceuticals (RCKT) | Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating pediatric diseases. It has two lentiviral vector (LVV) programs under clinical testing to treat fanconi anemia, a genetic defect in the bone marrow that reduces production of ...See Company Profile ...Dividend History | $24.01 | $2.19 billion |
| 245) | NextGen Healthcare (NXGN) | NextGen Healthcare, Inc. provides software, services, and analytics solutions to medical and dental group practices in the United States. The company's principal products include NextGen Enterprise EHR, which s...See Company Profile ...Dividend History | $23.91 | $1.6 billion |
| 246) | Retrophin (RTRX) | Retrophin, Inc. (Retrophin), incorporated on February 7, 2008, is a biopharmaceutical company. The Company is focused on the development, acquisition and commercialization of therapies for the treatment of serious, catastrophic ...See Company Profile ...Dividend History | $0 | $0 million |
| 247) | The Pennant Group (PNTG) | The Pennant Group, Inc. provides healthcare services in Arizona, California, Colorado, Idaho, Iowa, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington,...See Company Profile ...Dividend History | $19.91 | $605.95 million |
| 248) | HealthStream (HSTM) | HealthStream, Inc. (HealthStream), incorporated on September 27, 1990, provides workforce, patient experience and provider solutions for healthcare organizations. The Company operates in three segments: HealthStream Workforce Solutions, HealthStream Patient Experience ...See Company Profile ...Dividend History | $24.58 | $752.35 million |
| 249) | Pacific Biosciences of California (PACB) | Pacific Biosciences of California, Inc., incorporated on July 14, 2000, designs, develops and manufactures sequencing systems to help scientists resolve genetically complex problems. The Company is engaged in the development, ...See Company Profile ...Dividend History | $2.84 | $759.64 million |
| 250) | Y-mAbs Therapeutics (YMAB) | Y-mAbs Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel antibody therapeutic products for cancer treatment in the United States. It is developing naxitamab for the treatment of pediatric patients with relapsed or refractory, high-risk neuroblastoma, as well as other GD2 positive tumors; and omburtamab ...See Company Profile ...Dividend History | $14.91 | $652.72 million |
| 251) | Cytokinetics (CYTK) | Cytokinetics, Incorporated, incorporated on August 5, 1997, is a late-stage biopharmaceutical company. The Company is focused on discovering, developing and commercializing first-in-class muscle activators as potential treatments for debilitating diseases ...See Company Profile ...Dividend History | $68 | $7.49 billion |
| 252) | CryoPort (CYRX) | Cryoport, Inc. (Cryoport), incorporated on May 25, 1990, is a provider of cryogenic logistics solutions to the life sciences industry through its purpose-built packaging, information technology and specialized cold chain ...See Company Profile ...Dividend History | $17.02 | $860.38 million |
| 253) | Vanda Pharma (VNDA) | Vanda Pharmaceuticals Inc., incorporated on November 13, 2002, is a biopharmaceutical company. The Company is focused on the development and commercialization of therapies to address unmet medical needs. Its product ...See Company Profile ...Dividend History | $4.06 | $237.63 million |
| 254) | Athenex (ATNX) | Athenex, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of various therapies for the treatment of cancer and related conditions. The company's Orascovery product...See Company Profile ...Dividend History | $0.2 | $2.33 million |
| 255) | PetIQ (PETQ) | PetIQ, Inc. operates as a pet health and wellness company. It provides veterinarian services and veterinarian-grade pet products, including prescription (Rx) medications, over-the-counter (OTC) flea and tick pr...See Company Profile ...Dividend History | $16.18 | $484.73 million |
| 256) | Omeros (OMER) | Omeros Corporation, incorporated on June 16, 1994, is a biopharmaceutical company. The Company is engaged in discovering, developing and commercializing small-molecule and protein therapeutics for large-market, as well as orphan ...See Company Profile ...Dividend History | $3.38 | $218.84 million |
| 257) | Option Care Health, Inc. (OPCH) | Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides immunoglobulin infusion therapies for...See Company Profile | $30.91 | $5.37 billion |
| 258) | LeMaitre Vascular (LMAT) | LeMaitre Vascular, Inc., incorporated on June 15, 1998, is a provider of medical devices for the treatment of peripheral vascular disease. The Company develops, manufactures and markets medical devices and ...See Company Profile ...Dividend History | $64.45 | $1.44 billion |
| 259) | Cerus (CERS) | Cerus Corporation, incorporated on July 31, 1996, is a biomedical products company. The Company is engaged in developing and commercializing the INTERCEPT Blood System for blood safety. The Company operates ...See Company Profile ...Dividend History | $1.73 | $317.24 million |
| 260) | Brookdale Senior Living (BKD) | Brookdale Senior Living Inc., incorporated on June 28, 2005, operates senior living communities in the United States. The Company operates independent living, assisted living and dementia-care communities and continuing care ...See Company Profile ...Dividend History | $6.32 | $1.23 billion |
| 261) | ANI Pharma (ANIP) | ANI Pharmaceuticals, Inc., incorporated on April 11, 2001, is an integrated specialty pharmaceutical company. The Company is engaged in developing, manufacturing and marketing branded and generic prescription pharmaceuticals. The Company ...See Company Profile ...Dividend History | $66.3 | $1.4 billion |
| 262) | Flexion Therapeutics (FLXN) | Flexion Therapeutics, Inc., incorporated on November 5, 2007, is a specialty pharmaceutical company. The Company is focused on the development and commercialization of therapies for the treatment of patients with ...See Company Profile ...Dividend History | $9.12 | $458.93 million |
| 263) | Clovis Oncology (CLVS) | Clovis Oncology, Inc., incorporated on April 20, 2009, is a biopharmaceutical company focused on acquiring, developing and commercializing anti-cancer agents in the United States, Europe and other international markets. The ...See Company Profile ...Dividend History | $0.08 | $11.77 million |
| 264) | Eagle Pharma (EGRX) | Eagle Pharmaceuticals, Inc., incorporated on January 2, 2007, is a specialty pharmaceutical company. The Company focuses on developing and commercializing injectable products in the critical care and oncology areas. The ...See Company Profile ...Dividend History | $5.2 | $67.38 million |
| 265) | Krystal Biotech (KRYS) | Krystal Biotech, Inc., a gene therapy company, develops and commercializes pharmaceutical products for patients suffering from dermatological diseases in the United States. The company's lead product candidate ...See Company Profile ...Dividend History | $169.75 | $4.95 billion |
| 266) | Anika Therapeutics (ANIK) | Anika Therapeutics, Inc., incorporated on February 28, 1992, is an orthopedic medicines company. The Company is engaged in developing, manufacturing and commercializing products based on its hyaluronic acid (HA) technology. ...See Company Profile ...Dividend History | $25.31 | $375.85 million |
| 267) | Akebia Therapeutics (AKBA) | Akebia Therapeutics, Inc., incorporated on February 27, 2007, is a biopharmaceutical company. The Company focuses on the development and commercialization of therapeutics based on hypoxia-inducible factor (HIF) biology. The Companys ...See Company Profile ...Dividend History | $1.39 | $305.68 million |
| 268) | TherapeuticsMD (TXMD) | TherapeuticsMD, Inc., incorporated on July 20, 2010, is a womens healthcare company, which is engaged in creating and commercializing products for women. The Company is focused on pursuing the regulatory ...See Company Profile ...Dividend History | $1.95 | $22.95 million |
| 269) | AngioDynamics (ANGO) | AngioDynamics, Inc., incorporated on July 30, 1992, designs, manufactures and sells a range of medical, surgical and diagnostic devices used by professional healthcare providers for vascular access, for the treatment ...See Company Profile ...Dividend History | $6.31 | $254.74 million |
| 270) | Rhythm Pharmaceuticals (RYTM) | Rhythm Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of peptide therapeutics for the treatment of rare genetic disorders of obesity in the United States. Its peptide candidates include Setmelanotide, a melanocortin-4 receptor agonist, which is in Phase III clinical trial to treat POMC and leptin receptor ...See Company Profile ...Dividend History | $40.09 | $2.43 billion |
| 271) | Antares Pharma (ATRS) | Antares Pharma, Inc. (Antares), incorporated on April 29, 2005, is a specialty pharmaceutical company that focuses on developing and commercializing self-administered parenteral pharmaceutical products and technologies. The Company develops, manufactures ...See Company Profile ...Dividend History | $5.59 | $955.06 million |
| 272) | Allogene Therapeutics (ALLO) | Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, engages in the research, development, and commercialization of genetically engineered allogeneic T cell therapies for the treatment of canc...See Company Profile ...Dividend History | $3.55 | $642.55 million |
| 273) | Surmodics (SRDX) | Surmodics, Inc., incorporated on June 27, 1979, is a provider of medical device and in vitro diagnostic technologies to the healthcare industry. The Company operates through two segments: Medical Device ...See Company Profile ...Dividend History | $26.42 | $376.12 million |
| 274) | Kadmon (KDMN) | Kadmon Holdings, Inc., incorporated on September 15, 2010, is an integrated biopharmaceutical company engaged in the discovery, development and commercialization of small molecules and biologics to address disease areas of ...See Company Profile ...Dividend History | $9.5 | $1.7 billion |
| 275) | Karuna Therapeutics (KRTX) | Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, primarily focuses on developing novel therapies to address disabling neuropsychiatric conditions characterized by significant unmet medical needs. The company's lead product candidate is KarXT, an oral modulator that is in Phase II clinical trial for the treatment of acute psychosis in patients with schizophrenia, as well as in Phas...See Company Profile ...Dividend History | $316.24 | $12.06 billion |
| 276) | ZIOPHARM Oncology (ZIOP) | ZIOPHARM Oncology, Inc., a biotechnology company, focuses on acquiring, developing, and commercializing a portfolio of immuno-oncology therapies for treating heterogenous solid tumors and unknown anti...See Company Profile ...Dividend History | $0.87 | $187.12 million |
| 277) | Phibro Animal Health (PAHC) | Phibro Animal Health Corporation (Phibro), incorporated on January 27, 2014, is a global diversified animal health and mineral nutrition company. The Company operates in three segments, which include Animal Health, ...See Company Profile ...Dividend History | $13.21 | $531 million |
| 278) | Collegium Pharmaceutical (COLL) | Collegium Pharmaceutical, Inc., incorporated on July 01, 2014, is a specialty pharmaceutical company. The Company is engaged in developing and commercializing abuse-deterrent products that incorporate its DETERx platform technology for ...See Company Profile ...Dividend History | $35.14 | $1.17 billion |
| 279) | Accelerate Diagnostics (AXDX) | Accelerate Diagnostics, Inc., incorporated on December 24, 2012, is an in vitro diagnostics company engaged in providing solutions that develop patient outcomes through the diagnosis of serious infections. The Companys ...See Company Profile ...Dividend History | $0.91 | $19.72 million |
| 280) | Assembly Biosciences (ASMB) | Assembly Biosciences, Inc. operates as a clinical stage biotechnology company. It develops oral therapeutic candidates for the treatment of hepatitis B virus (HBV) infection and novel class of oral sy...See Company Profile ...Dividend History | $14.93 | $82.7 million |
| 281) | G1 Therapeutics (GTHX) | G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel small molecule therapeutics for the treatment of patients with cancer in ...See Company Profile ...Dividend History | $4.31 | $224.98 million |
| 282) | OraSure (OSUR) | OraSure Technologies, Inc. (OraSure), incorporated on May 5, 2000, is involved in the development, manufacture, marketing and sale of oral fluid diagnostic products and specimen collection devices using its technologies, ...See Company Profile ...Dividend History | $5.41 | $413.92 million |
| 283) | Triple-S Management (GTS) | Triple-S Management Corporation, through its subsidiaries, provides a portfolio of managed care and related products in the commercial, Medicare, and Medicaid markets in Puerto Rico, the United States...See Company Profile ...Dividend History | $35.99 | $856.4 million |
| 284) | AVROBIO (AVRO) | AVROBIO, Inc., a clinical stage gene therapy company, focuses on developing ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose. The company's gene therapies employ hematopoie...See Company Profile ...Dividend History | $1.26 | $57 million |
| 285) | OrthoPediatrics (KIDS) | OrthoPediatrics Corp., a medical device company, designs, develops, and markets anatomically appropriate implants and devices for the treatment of children with orthopedic conditions in the United States and in...See Company Profile ...Dividend History | $30.45 | $739.52 million |
| 286) | MacroGenics (MGNX) | MacroGenics, Inc., incorporated on August 14, 2000, is a clinical-stage biopharmaceutical company focused on discovering and developing monoclonal antibody-based therapeutics for the treatment of cancer, as well as various autoimmune ...See Company Profile ...Dividend History | $16.94 | $1.06 billion |
| 287) | Meridian Bioscience (VIVO) | Meridian Bioscience, Inc., incorporated on June 25, 1976, is a life science company. The Company is engaged in the development, manufacture, sale and distribution of diagnostic test kits for gastrointestinal, ...See Company Profile ...Dividend History | $33.97 | $1.49 billion |
| 288) | Inovio Pharma (INO) | Inovio Pharmaceuticals, Inc. (Inovio), incorporated on June 15, 2001, is a clinical-stage pharmaceutical company, which is involved in developing deoxyribonucleic acid (DNA) immunotherapies and vaccines focused on treating and preventing ...See Company Profile ...Dividend History | $10.99 | $257.78 million |
| 289) | Prothena (PRTA) | Prothena Corporation Public Limited Company, incorporated on September 26, 2012, is a global biotechnology company. The Company is focused on the discovery, development and commercialization of immunotherapies for the treatment ...See Company Profile ...Dividend History | $21.99 | $1.18 billion |
| 290) | Axonics Modulation (AXNX) | Axonics Modulation Technologies, Inc., a medical technology company, focuses on the design, development, and commercialization of sacral neuromodulation solutions (SNM) solutions. The SNM therapy is primarily u...See Company Profile ...Dividend History | $67.33 | $3.45 billion |
| 291) | Tilray (TLRY) | Tilray, Inc. engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, ...See Company Profile ...Dividend History | $1.78 | $1.4 billion |
| 292) | BioCryst Pharma (BCRX) | BioCryst Pharmaceuticals, Inc., incorporated on November 15, 1991, is a biotechnology company. The Company designs, optimizes and develops small molecule drugs that block enzymes involved in the pathogenesis of diseases. ...See Company Profile ...Dividend History | $4.67 | $981.23 million |
| 293) | Dynavax (DVAX) | Dynavax Technologies Corporation (Dynavax), incorporated on November 6, 2000, is a clinical-stage immunotherapy company focused on leveraging the bodys innate and adaptive immune responses through toll-like receptor (TLR) stimulation. The ...See Company Profile ...Dividend History | $11.69 | $1.55 billion |
| 294) | Kura Oncology (KURA) | Kura Oncology, Inc., incorporated on November 16, 2007, is a clinical-stage biopharmaceutical company. The Company is engaged in discovering and developing personalized therapeutics for the treatment of solid tumors and ...See Company Profile ...Dividend History | $19.01 | $1.48 billion |
| 295) | PDL BioPharma (PDLI) | PDL BioPharma, Inc., incorporated on July 24, 1986, seeks to provide return for its shareholders by acquiring and managing a portfolio of companies, products, royalty agreements and debt facilities in ...See Company Profile ...Dividend History | $2.47 | $282.14 million |
| 296) | Viking Therapeutics (VKTX) | Viking Therapeutics, Inc., incorporated on October 24, 2012, is a clinical-stage biopharmaceutical company. The Company focuses on the development of therapies for metabolic and endocrine disorders. The Companys clinical program, ...See Company Profile ...Dividend History | $66.95 | $7.56 billion |
| 297) | Apollo Medical Holdings, Inc. (AMEH) | Apollo Medical Holdings, Inc., a physician-centric technology-powered healthcare management company, provides medical care services. The company is...See Company Profile | $38.5 | $1.75 billion |
| 298) | Agenus (AGEN) | Agenus Inc., a clinical-stage immuno-oncology company, focuses on the discovery and development of therapies that engage the body's immune system to fight cancer. The company offers Retrocyte Display,...See Company Profile ...Dividend History | $6.5 | $170.71 million |
| 299) | Intellia Therapeutics (NTLA) | Intellia Therapeutics, Inc., incorporated on May 7, 2014, is a genome editing company. The Company is focused on developing therapeutics utilizing a biological tool known as CRISPR/Cas9. The CRISPR/Cas9 genome ...See Company Profile ...Dividend History | $22.92 | $2.33 billion |
| 300) | Odonate Therapeutics (ODT) | Odonate Therapeutics, Inc., a pharmaceutical company, develops therapeutics for the treatment of cancer. It focuses on the development of tesetaxel, an orally administered chemotherapy agent for patients with a...See Company Profile ...Dividend History | $1.12 | $43.11 million |
| 301) | AxoGen (AXGN) | AxoGen, Inc., incorporated on June 20, 1977, offers surgical solutions for peripheral nerve injuries. The Company provides products and education to improve surgical treatment algorithms for peripheral nerve injuries. Its ...See Company Profile ...Dividend History | $7.03 | $315.21 million |
| 302) | Progenics Pharma (PGNX) | Progenics Pharmaceuticals, Inc., incorporated on December 1, 1986, is engaged in developing medicines and other products for targeting and treating cancer. The Companys pipeline includes therapeutic agents designed to target ...See Company Profile ...Dividend History | $0 | $0 million |
| 303) | Corbus Pharma (CRBP) | Corbus Pharmaceuticals Holdings, Inc., incorporated on December 18, 2013, is a clinical-stage pharmaceutical company. The Company is focused on the development and commercialization of therapeutics to treat rare, chronic and ...See Company Profile ...Dividend History | $42.72 | $448.87 million |
| 304) | Cross Country Healthcare (CCRN) | Cross Country Healthcare, Inc., incorporated on May 20, 1999, is engaged in providing healthcare recruiting, staffing, recruiting and workforce solutions. The Company operates in three segments: Nurse and Allied Staffing, ...See Company Profile ...Dividend History | $17.74 | $615.18 million |
| 305) | Simulations Plus (SLP) | Simulations Plus, Inc., incorporated on July 17, 1996, is a provider of simulation and modeling software for pharmaceutical discovery and development. The Company offers its products and services through two ...See Company Profile ...Dividend History | $45.7 | $913.31 million |
| 306) | Community Health (CYH) | Community Health Systems, Inc., incorporated on June 6, 1996, is an operator of general acute care hospitals and outpatient facilities in communities across the country. The Company operates through hospital ...See Company Profile ...Dividend History | $3 | $416.95 million |
| 307) | Rigel Pharma (RIGL) | Rigel Pharmaceuticals, Inc., incorporated on June 14, 1996, is a clinical-stage biotechnology company. The Company is engaged in the discovery and development of targeted drugs in the therapeutic areas of ...See Company Profile ...Dividend History | $1.15 | $201.72 million |
| 308) | Accuray (ARAY) | Accuray Incorporated, incorporated on February 22, 2001, is a radiation oncology company. The Company develops, manufactures, sells and supports treatment solutions. It develops, manufactures and markets medical devices used in ...See Company Profile ...Dividend History | $2.31 | $229.08 million |
| 309) | Sorrento Therapeutics (SRNE) | Sorrento Therapeutics, Inc., incorporated on December 4, 2009, is a biopharmaceutical company. The Company is engaged in the discovery, acquisition, development and commercialization of drug therapeutics. Its primary therapeutic focus ...See Company Profile ...Dividend History | $0.31 | $168.36 million |
| 310) | CytomX Therapeutics (CTMX) | CytomX Therapeutics, Inc., incorporated on September 16, 2010, is a clinical-stage, oncology-focused biopharmaceutical company. The Company uses its Probody technology platform to create cancer immunotherapies against clinically validated targets, as ...See Company Profile ...Dividend History | $1.97 | $133.43 million |
| 311) | Eidos Therapeutics (EIDX) | Eidos Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on developing drugs to treat diseases caused by transthyretin (TTR) amyloidosis (ATTR). It is developing AG10, an orally-administere...See Company Profile ...Dividend History | $122.21 | $4.75 billion |
| 312) | Quanterix (QTRX) | Quanterix Corporation, a life sciences company, develops and markets ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics in North America, Euro...See Company Profile ...Dividend History | $17.15 | $652.79 million |
| 313) | Surgery Partners (SGRY) | Surgery Partners, Inc., incorporated on April 2, 2015, is a healthcare services company. The Company operates in three lines of business across the United States: Surgical Facility Services, Ancillary Services ...See Company Profile ...Dividend History | $25.67 | $3.33 billion |
| 314) | ViewRay (VRAY) | ViewRay, Inc., incorporated on October 6, 2013, through its subsidiary ViewRay Technologies, Inc., designs, manufactures and markets MRIdian, the magnetic resonance imaging (MRI)-guided radiation therapy system to image and treat ...See Company Profile ...Dividend History | $0.03 | $4.59 million |
| 315) | Computer Programs and (CPSI) | Computer Programs and Systems, Inc. (CPSI), incorporated on March 13, 2002, is a provider of healthcare information technology (IT) solutions for rural and community hospitals, and post-acute care facilities. The ...See Company Profile ...Dividend History | $9.19 | $133.71 million |
| 316) | Homology Medicines (FIXX) | Homology Medicines, Inc., a genetic medicines company, focuses on translating proprietary gene editing and gene therapy technologies into novel treatments for patients with rare diseases. Its proprietary platfo...See Company Profile ...Dividend History | $0.89 | $51.92 million |
| 317) | Akcea Therapeutics (AKCA) | Akcea Therapeutics, Inc., a late-stage biopharmaceutical company, focuses on developing and commercializing drugs to treat patients with cardiometabolic diseases caused by lipid disorders in the United States a...See Company Profile ...Dividend History | $0 | $0 million |
| 318) | Voyager Therapeutics (VYGR) | Voyager Therapeutics, Inc., incorporated on June 19, 2013, is a clinical-stage gene therapy company. The Company focuses on developing treatments for patients suffering from severe diseases of the central nervous ...See Company Profile ...Dividend History | $8.24 | $457.2 million |
| 319) | Shockwave Medical (SWAV) | ShockWave Medical, Inc., a medical device company, develops and commercializes intravascular lithotripsy technology to treat calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease; C2 catheters for treating coronary artery disease; and S4 catheters or treating bel...See Company Profile ...Dividend History | $327.1 | $12.29 billion |
| 320) | SI-BONE (SIBN) | SI-BONE, Inc., a medical device company, develops and commercializes a proprietary minimally invasive surgical implant system in the United States and Internationally. It offers iFuse, an implant system to fuse...See Company Profile ...Dividend History | $15.27 | $627.06 million |
| 321) | Twist Bioscience (TWST) | Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for drug discovery and development, ...See Company Profile ...Dividend History | $29.24 | $1.69 billion |
| 322) | Stemline Therapeutics (STML) | Stemline Therapeutics, Inc., incorporated on August 8, 2003, is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing oncology therapeutics. The Company is developing approximately three clinical stage ...See Company Profile ...Dividend History | $0 | $0 million |
| 323) | GenMark Diagnostics (GNMK) | GenMark Diagnostics, Inc., incorporated on February 12, 2010, is a molecular diagnostics company. The Company is focused on developing and commercializing multiplex molecular tests that aid in the diagnosis of ...See Company Profile ...Dividend History | $24.04 | $1.77 billion |
| 324) | Gossamer Bio (GOSS) | Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. It is developing GB001, an oral antagonist of prostaglandin D2 receptor 2 that is in Phase IIb clinical trial for the treatment of moderate-to-severe eosinophilic asthma, as we...See Company Profile ...Dividend History | $0.86 | $201.52 million |
| 325) | SIGA Technologies (SIGA) | SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security markets in the United States. Its lead product is TPOXX, an orally administered antiviral drug for the treatmen...See Company Profile ...Dividend History | $8.88 | $631.29 million |
| 326) | Rubius Therapeutics (RUBY) | Rubius Therapeutics, Inc. focuses on the development of red cell therapeutics (RCTs) for the treatment of patients with severe diseases through its rubius erythrocyte design cellular therapy platform. The company is developing various RCTs, such as RTX-134 for treatment of classic and moderate phenylketonuria; RTX-Uricase 002FURAT1 for treatment of chronic ...See Company Profile ...Dividend History | $0.02 | $1.58 million |
| 327) | Minerva Neurosciences (NERV) | Minerva Neurosciences, Inc., incorporated on April 23, 2007, is a clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of a portfolio of product candidates to treat ...See Company Profile ...Dividend History | $2.42 | $17.2 million |
| 328) | Invacare (IVC) | Invacare Corporation, incorporated on March 23, 1971, is a manufacturer and distributor for medical equipment used in non-acute care settings. The Company designs, manufactures and distributes medical devices help people ...See Company Profile ...Dividend History | $0.66 | $24.91 million |
| 329) | Evolus (EOLS) | Evolus, Inc. provides medical aesthetic products for physicians and their patients in the United States. It offers DWP-450, an injectable 900 kilodalton botulinum toxin type A complex designed to address the ne...See Company Profile ...Dividend History | $11.89 | $743.51 million |
| 330) | Scholar Rock Holding (SRRK) | Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery and development of various medicines for the treatment of serious diseases in which signaling by protein growth factors pl...See Company Profile ...Dividend History | $13.33 | $1.05 billion |
| 331) | Concert Pharma (CNCE) | Concert Pharmaceuticals, Inc., incorporated on April 12, 2006, is a clinical-stage biopharmaceutical company. The Company is engaged in the discovery and development of small molecule drugs. The Company operates through ...See Company Profile ...Dividend History | $8.37 | $401.95 million |
| 332) | Madrigal Pharma (MDGL) | Madrigal Pharmaceuticals, Inc., formerly Synta Pharmaceuticals Corp., incorporated on March 10, 2000, is a clinical-stage biopharmaceutical company. The Company focuses on the development and commercialization of therapeutic candidates for the ...See Company Profile ...Dividend History | $231.37 | $4.96 billion |
| 333) | Geron (GERN) | Geron Corporation (Geron), incorporated on November 28, 1990, is a biopharmaceutical company, which supports the clinical stage development of a telomerase inhibitor, Imetelstat, in hematologic myeloid malignancies by Janssen Biotech, ...See Company Profile ...Dividend History | $3.45 | $2.14 billion |
| 334) | Stoke Therapeutics (STOK) | Stoke Therapeutics, Inc., an early-stage biopharmaceutical company, develops antisense oligonucleotide medicines to treat the underlying causes of severe genetic diseases. Its lead product candidate, STK-001, to treat Dravet syndrome, a severe and progressive genetic epilepsy. Stoke Therapeutics, Inc. has a partnership with Invitae Corporation to offer epilepsy panel testing. The company was formerly k...See Company Profile ...Dividend History | $12.21 | $660.62 million |
| 335) | Amneal Pharmaceuticals (AMRX) | Amneal Pharmaceuticals, Inc., a specialty pharmaceutical company, develops, manufactures, markets, and distributes generic pharmaceutical products for various dosage forms and therapeutic areas. It operates thr...See Company Profile ...Dividend History | $5.54 | $1.71 billion |
| 336) | MediciNova (MNOV) | MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. The company is dev...See Company Profile ...Dividend History | $1.54 | $77 million |
| 337) | Syros Pharma (SYRS) | Syros Pharmaceuticals, Inc., incorporated on November 9, 2011, is a biopharmaceutical company. The Company offers a gene control platform designed to analyze the unexploited region of deoxyribonucleic acid (DNA) in ...See Company Profile ...Dividend History | $5.35 | $142.59 million |
| 338) | Crinetics Pharmaceuticals (CRNX) | Crinetics Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. I...See Company Profile ...Dividend History | $43.68 | $3.4 billion |
| 339) | Arcus Biosciences (RCUS) | Arcus Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing cancer immunotherapies in the United States. It is developing various products for treating solid tumors, including AB928, an adenosine receptor antagonist that is in Phase I clinical trial; AB680, a CD73 inhibitor; AB122, an anti-PD-1 antibody that is ...See Company Profile ...Dividend History | $16.29 | $1.48 billion |
| 340) | KalVista Pharma (KALV) | KalVista Pharmaceuticals, Inc., formerly Carbylan Therapeutics, Inc., incorporated on March 26, 2004, is a clinical-stage pharmaceutical company. The Company is focused on the discovery, development, and commercialization of small molecule ...See Company Profile ...Dividend History | $11.74 | $495.29 million |
| 341) | Kiniksa Pharmaceuticals (KNSA) | Kiniksa Pharmaceuticals, Ltd., a clinical-stage biopharmaceutical company, focuses on the discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating d...See Company Profile ...Dividend History | $17.44 | $1.22 billion |
| 342) | Gritstone Oncology (GRTS) | Gritstone Oncology Inc. is engaged in the discovery and development of cancer immunotherapies. The company focuses on developing tumor-specific neo-antigens-based therapies for non-small cell lung cancer. Grits...See Company Profile ...Dividend History | $0.74 | $89.85 million |
| 343) | Xeris Pharmaceuticals (XERS) | Xeris Pharmaceuticals, Inc., a specialty pharmaceutical company, develops and commercializes ready-to-use injectable and infusible drug formulations. Its proprietary XeriSol and XeriJect formulation technologies allow for the subcutaneous and intramuscular delivery of highly-concentrated, ready-to-use formulations of peptides, proteins, antibodies, and small molecules using commercially available syrin...See Company Profile ...Dividend History | $1.85 | $268.22 million |
| 344) | Mallinckrodt (MNK) | Mallinckrodt public limited company, incorporated on January 9, 2013, develops, manufactures, markets and distributes branded and generic specialty pharmaceutical products and therapies. The Company focuses on various therapeutic areas, such ...See Company Profile ...Dividend History | $0.34 | $4.52 million |
| 345) | Nextcure (NXTC) | NextCure, Inc., a biopharmaceutical company, engages in discovering and developing immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function. Its lead product candidate is NC318, which is in Phase Iu002FII clinical trials for the treatment of advanced or metastatic solid tumors. The company is also developing NC410, is a novel immunomedicine designed to block...See Company Profile ...Dividend History | $1.67 | $54.22 million |
| 346) | OptiNose (OPTN) | OptiNose, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for patients treated by ear, nose, and throat; and allergy specialists in the United States. The ...See Company Profile ...Dividend History | $1.19 | $134.06 million |
| 347) | Five Prime Therapeutics (FPRX) | Five Prime Therapeutics, Inc., incorporated on December 20, 2001, is a clinical-stage biotechnology company focused on discovering and developing protein therapeutics. The Company has three product candidates in clinical development ...See Company Profile ...Dividend History | $38 | $1.77 billion |
| 348) | Verrica Pharmaceuticals (VRCA) | Verrica Pharmaceuticals Inc. develops and commercializes dermatological treatments in the United States. The company is advancing its lead product VP-102, a proprietary topical therapy, in various common skin indications, including Molluscum contagiosum and Verruca Vulgaris. It is also developing 2 Phase 3 trials in molluscum contagiosum under NCT03377803 and NCT03377790. ...See Company Profile ...Dividend History | $6.92 | $293.54 million |
| 349) | Replimune Group (REPL) | Replimune Group, Inc., a clinical-stage biotechnology company, focuses on the development of oncolytic immunotherapies to treat cancer. The company uses its proprietary Immulytic platform to design and develop product candidates that are intended to activate the immune system against cancer. Its lead product candidate is RP1, a selectively replicating version ...See Company Profile ...Dividend History | $7.12 | $437.08 million |
| 350) | Tcr2 Therapeutics (TCRR) | TCR2 Therapeutics Inc., a clinical-stage immunotherapy company, develops novel T cell receptor therapies for patients suffering from cancer. The company's lead product candidates include TC-210, mono TCR Fusion Construct T cells (TRuC-T cells) targeting mesothelin positive solid tumors, which initiated in phase Iu002FII clinical trial for the treatment of non-small cell lung cancer (NSCLC), ovarian can...See Company Profile ...Dividend History | $1.58 | $62.03 million |
| 351) | Lexicon Pharma (LXRX) | Lexicon Pharmaceuticals, Inc., incorporated on July 7, 1995, is a biopharmaceutical company. The Company focuses on the development and commercialization of breakthrough treatments for human disease. The Companys drug programs ...See Company Profile ...Dividend History | $1.87 | $460.46 million |
| 352) | Transgenomic (TBIO) | Transgenomic, Inc. (Transgenomic), incorporated on March 6, 1997, is a biotechnology company. The Company is engaged in advancing personalized medicine for the detection and treatment of cancer, and inherited diseases ...See Company Profile ...Dividend History | $0.38 | $11.37 million |
| 353) | Personalis (PSNL) | Personalis, Inc. operates as a cancer genomics company worldwide. The company provides sequencing and data analysis services to support the development of cancer therapies. It offers NeXT Platform, which provides data for cancer therapy development, personalized therapies, therapy selection, and diagnostics. The company also provides a complementary liquid biopsy assay that analyzes various human genes...See Company Profile ...Dividend History | $1.26 | $65.29 million |
| 354) | Transmedics Group (TMDX) | Transmedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor ...See Company Profile ...Dividend History | $91.82 | $3.02 billion |
| 355) | Akero Therapeutics (AKRO) | Akero Therapeutics, Inc., a clinical-stage biotechnology company, engages in the development and commercialization of transformative treatments for serious metabolic diseases with high unmet medical need. Its lead product candidate is AKR-001, which completed Phase Ib clinical trial for the treatment of non-alcoholic steatohepatitis disease. The company was formerly known as Pippin Pharmaceuticals, Inc...See Company Profile ...Dividend History | $21.72 | $1.53 billion |
| 356) | Morphic Holding (MORF) | Morphic Holding, Inc., a biopharmaceutical company, focuses on the discovery and development of oral small-molecule integrin therapeutics. The company's lead product candidates in clinical development are MORF-720, a selective oral avb6 specific integrin inhibitor for the treatment of idiopathic pulmonary fibrosis; and a4b7 specific integrin inhibitors for the treatment of inflammatory bowel disease. I...See Company Profile ...Dividend History | $29.51 | $1.48 billion |
| 357) | Kala Pharmaceuticals (KALA) | Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies using its proprietary nanoparticle-based Mucus Penetrating Particles (MPP) technology for t...See Company Profile ...Dividend History | $7 | $20.28 million |
| 358) | Castlight Health (CSLT) | Castlight Health, Inc., incorporated on January 31, 2008, offers a health benefits platform that engages employees to make healthcare decisions, and enables employers to communicate and measure their benefit programs. ...See Company Profile ...Dividend History | $2.05 | $335.49 million |
| 359) | Precision Biosciences (DTIL) | Precision BioSciences, Inc. operates as a genome editing company and develops therapeutic products in the United States. It operates through two segments, Therapeutic and Food. The company offers ARCUS, a genome editing platform to cure cancers and genetic disorders. The Therapeutic segment develops allogeneic CAR T immunotherapy that recognizes and kills cancer cells; and engages in the in vivo gene c...See Company Profile ...Dividend History | $13.06 | $98.11 million |
| 360) | Calyxt (CLXT) | Calyxt, Inc., a consumer-centric food- and agriculture-focused company, develops healthier specialty food ingredients and food crops using gene-editing technology for plants in the United States. It engages in ...See Company Profile ...Dividend History | $5.39 | $26.81 million |
| 361) | Prevail Therapeutics (PRVL) | Prevail Therapeutics Inc., a gene therapy company, focuses on developing and commercializing disease-modifying AAV-based gene therapies for patients with devastating neurodegenerative diseases. The company's lead product candidate is PR001 for the treatment of Parkinson's disease with GBA1 mutation and neuronopathic Gaucher disease. It is also developing PR006 for the treatment of frontotemporal dement...See Company Profile ...Dividend History | $23 | $787.7 million |
| 362) | Marker Therapeutics (MRKR) | Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, engages in the development of next-generation T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor in...See Company Profile ...Dividend History | $4.44 | $39.53 million |
| 363) | PhaseBio Pharmaceuticals (PHAS) | PhaseBio Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapies to treat orphan diseases with an initial focus on cardiopulmonary ...See Company Profile ...Dividend History | $0.07 | $3.5 million |
| 364) | Akorn (AKRX) | Akorn Inc. (Akorn), incorporated on January 20, 1971, together with its subsidiaries, is a specialty generic pharmaceutical company that develops, manufactures and markets generic and branded prescription pharmaceuticals, as well ...See Company Profile ...Dividend History | $0 | $0 million |
| 365) | Avalon GloboCare (AVCO) | Avalon GloboCare Corp., together with its subsidiaries, engages in integrating and managing healthcare services and resources in the United States. It provides medical related consulting services and develops A...See Company Profile ...Dividend History | $0.53 | $52.18 million |
| 366) | GlycoMimetics (GLYC) | GlycoMimetics, Inc., incorporated on April 4, 2003, is a clinical-stage biotechnology company. The Company focuses on the discovery and development of glycomimetic drugs. The Company operates through the identification and ...See Company Profile ...Dividend History | $2.26 | $153.05 million |
| 367) | Neuronetics (STIM) | Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with psychiatric disorders. It offers NeuroStar Advanced Therapy System, a non-invasive and...See Company Profile ...Dividend History | $4.16 | $124.69 million |
| 368) | Eloxx Pharmaceuticals (ELOX) | Eloxx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel therapeutics for the treatment of rare and ultra-rare premature stop codon diseases. Its lead...See Company Profile ...Dividend History | $4.76 | $14.56 million |
| 369) | Opko Health (OPK) | OPKO Health, Inc., incorporated on November 18, 1991, is a diversified healthcare company. The Companys segments include Pharmaceutical, Diagnostics and Corporate. The pharmaceutical segment consists of the pharmaceutical operations in ...See Company Profile ...Dividend History | $1.23 | $857.3 million |
| 370) | AnaptysBio (ANAB) | AnaptysBio, Inc., a clinical stage biotechnology company, engages in developing antibody product candidates focused on unmet medical needs in inflammation. The company's proprietary anti-inflammatory pipeline i...See Company Profile ...Dividend History | $21.27 | $608.59 million |
| 371) | Precigen, Inc. (PGEN) | Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying...See Company Profile | $1.4 | $355.95 million |
| 372) | Spectrum Pharma (SPPI) | Spectrum Pharmaceuticals, Inc., incorporated on November 18, 2002, is a biotechnology company. The Company operates through developing and commercializing oncology and hematology drug products segment. It has a product portfolio ...See Company Profile ...Dividend History | $1.03 | $211.4 million |
| 373) | Puma Biotechnology (PBYI) | Puma Biotechnology, Inc., incorporated on September 15, 2010, is a biopharmaceutical company that focuses on the development and commercialization of products for the treatment of cancer. The Company focuses on ...See Company Profile ...Dividend History | $5.35 | $257.91 million |
| 374) | Diplomat Pharmacy (DPLO) | Diplomat Pharmacy, Inc. (Diplomat), incorporated on March 26, 1975, operates a specialty pharmacy business, which stocks, dispenses and distributes prescriptions for various biotechnology and specialty pharmaceutical manufacturers. The Company operates ...See Company Profile ...Dividend History | $0 | $0 million |
| 375) | WAVE Life Sciences (WVE) | WAVE Life Sciences Ltd. is a genetic medicines company. The Company, through its synthetic chemistry drug development platform, designs, develops and commercializes a pipeline of nucleic acid therapeutic candidates for ...See Company Profile ...Dividend History | $5.74 | $709.25 million |
| 376) | Acorda Therapeutics (ACOR) | Acorda Therapeutics, Inc., incorporated on March 17, 1995, is a biopharmaceutical company. The Company focuses on developing therapies that restore function and improve the lives of people with neurological disorders. ...See Company Profile ...Dividend History | $13.47 | $16.73 million |
| 377) | CymaBay Therapeutics (CBAY) | CymaBay Therapeutics, Inc., incorporated on October 5, 1988, is a clinical-stage biopharmaceutical company. The Company is focused on developing therapies to treat metabolic diseases, including serious rare and orphan diseases. ...See Company Profile ...Dividend History | $32.23 | $3.7 billion |
| 378) | AMAG Pharma (AMAG) | AMAG Pharmaceuticals, Inc., incorporated on November 9, 1981, is a pharmaceutical company. The Companys segment is the manufacture, development and commercialization of products and services for use in treating various ...See Company Profile ...Dividend History | $0 | $0 million |
| 379) | Solid Biosciences (SLDB) | Solid Biosciences Inc. engages in identifying and developing therapies for duchenne muscular dystrophy in the United States. Its lead product candidate includes SGT-001, a gene therapy that is in Phase I I...See Company Profile ...Dividend History | $10 | $377.57 million |
| 380) | Cyclerion Therapeutics (CYCN) | Cyclerion Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovering, development, and commercialization of various treatments...See Company Profile ...Dividend History | $3.32 | $9.13 million |
| No. | Company / Security |
|---|---|
| 1) | U.S. Dollar |
| 2) | NovoCure Ltd. |
| 3) | uniQure N.V. |
| 4) | CRISPR Therapeutics AG |
| 5) | Myovant Sciences Ltd. |
| 6) | Establishment Labs Holdings, Inc. |
| 7) | MeiraGTx Holdings Plc |
| 8) | EQUITY OTHER |
◐ List of 0.5x Leveraged ETFs
◐ List of 1.25x Leveraged Equities ETFs
◐ List of 1.25x Leveraged ETFs
◐ List of 1.5x Leveraged ETFs
◐ List of 2x Leveraged Bond ETFs
◐ List of 2x Leveraged Bonds ETFs
◐ List of 2x Leveraged Equities ETFs
◐ List of 2x Leveraged ETFs
◐ List of 3x Leveraged Bond ETFs
◐ List of 3x Leveraged Bonds ETFs
◐ List of 3x Leveraged Equities ETFs
◐ List of 3x Leveraged Equity ETFs
◐ List of 3x Leveraged ETFs
◐ List of 4x Leveraged ETFs
◐ List of 5g ETFs
◐ List of Aerospace Defense ETFs
◐ List of Aerospace ETFs
◐ List of Africa ETFs
◐ List of Agriculture ETFs
◐ List of Airlines ETFs
◐ List of All Cap Equities ETFs
◐ List of All Term Duration Bond ETFs
◐ List of Alternatives ETFs
◐ List of Aluminum ETFs
◐ List of Argentina ETFs
◐ List of Artificial Intelligence ETFs
◐ List of Asia ETFs
◐ List of Australia ETFs
◐ List of Bank ETFs
◐ List of Basic Industries ETFs
◐ List of Basic Materials ETFs
◐ List of Biofuels ETFs
◐ List of Biotech ETFs
◐ List of Bitcoin ETFs
◐ List of Blend ETFs
◐ List of Blockchain ETFs
◐ List of Bond Duration ETFs
◐ List of Bond ETFs
◐ List of Bonds ETFs
◐ List of Brazil ETFs
◐ List of Broad Asia ETFs
◐ List of Canada ETFs
◐ List of Cannabis ETFs
◐ List of China ETFs
◐ List of Clean Energy ETFs
◐ List of Cloud Computing ETFs
◐ List of Coffee ETFs
◐ List of Commodities ETFs
◐ List of Communication ETFs
◐ List of Consumer Discretionary ETFs
◐ List of Corporate Bond ETFs
◐ List of Developed Asia ETFs
◐ List of Dividend Aristocrats ETFs
◐ List of Dividend ETFs
◐ List of Dogs Of The Dow ETFs
◐ List of Dow Jones ETFs
◐ List of Electric Vehicles ETFs
◐ List of Emerging Asia ETFs
◐ List of Energy ETFs
◐ List of Esg ETFs
◐ List of Food & Beverage ETFs
◐ List of Gaming ETFs
◐ List of Germany ETFs
◐ List of Global ETFs
◐ List of Gold Miners ETFs
◐ List of Gold ETFs
◐ List of Growth ETFs
◐ List of Healthcare ETFs
◐ List of Hedge Fund ETFs
◐ List of High Beta ETFs
◐ List of High Yield ETFs
◐ List of India ETFs
◐ List of Intermediate Term Duration Bond ETFs
◐ List of Internet ETFs
◐ List of Inverse Bond ETFs
◐ List of Inverse Equity ETFs
◐ List of Inverse Gold ETFs
◐ List of Inverse Market Cap ETFs
◐ List of Inverse Oil ETFs
◐ List of Inverse S&p 500 ETFs
◐ List of Inverse Vix ETFs
◐ List of Iron ETFs
◐ List of Italy ETFs
◐ List of Large Cap Blend ETFs
◐ List of Large Cap Growth ETFs
◐ List of Large Cap Value ETFs
◐ List of Large Cap ETFs
◐ List of Leveraged Agriculture ETFs
◐ List of Leveraged Bond ETFs
◐ List of Leveraged Bonds ETFs
◐ List of Leveraged Commodities ETFs
◐ List of Leveraged Currency ETFs
◐ List of Leveraged Energy ETFs
◐ List of Leveraged Equities ETFs
◐ List of Leveraged Gold ETFs
◐ List of Leveraged Large Cap ETFs
◐ List of Leveraged Mega Cap ETFs
◐ List of Leveraged Micro Cap ETFs
◐ List of Leveraged Mid Cap ETFs
◐ List of Leveraged Multi Asset ETFs
◐ List of Leveraged Multi Cap ETFs
◐ List of Leveraged Natural Gas ETFs
◐ List of Leveraged Oil ETFs
◐ List of Leveraged Precious Metals ETFs
◐ List of Leveraged Real Estate ETFs
◐ List of Leveraged Reit ETFs
◐ List of Leveraged Silver ETFs
◐ List of Leveraged Small Cap ETFs
◐ List of Leveraged Volatility ETFs
◐ List of Long Term Duration Bond ETFs
◐ List of Low Volatility ETFs
◐ List of Mbs ETFs
◐ List of Meat ETFs
◐ List of Media ETFs
◐ List of Mega Cap Blend ETFs
◐ List of Mega Cap ETFs
◐ List of Metals ETFs
◐ List of Mexico ETFs
◐ List of Micro Cap Blend ETFs
◐ List of Micro Cap ETFs
◐ List of Mid Cap Blend ETFs
◐ List of Mid Cap Growth ETFs
◐ List of Mid Cap Value ETFs
◐ List of Mid Cap ETFs
◐ List of Momentum ETFs
◐ List of Most Diversified ETFs
◐ List of Multi Asset ETFs
◐ List of Multi Cap Blend ETFs
◐ List of Multi Cap ETFs
◐ List of Nasdaq 100 ETFs
◐ List of Nasdaq ETFs
◐ List of Natural Gas ETFs
◐ List of Natural Resources ETFs
◐ List of Negative Duration Bond ETFs
◐ List of No Underlying Index ETFs
◐ List of Oil ETFs
◐ List of Palladium ETFs
◐ List of Pharma ETFs
◐ List of Pharmaceutical ETFs
◐ List of Platinum ETFs
◐ List of Precious Metals ETFs
◐ List of Preferred Stock ETFs
◐ List of Private Equity ETFs
◐ List of Quant ETFs
◐ List of Real Estate ETFs
◐ List of Reit ETFs
◐ List of Renewable Energy ETFs
◐ List of Robotics ETFs
◐ List of Russell 2000 ETFs
◐ List of Russia ETFs
◐ List of S&p 500 ETFs
◐ List of S&p Index ETFs
◐ List of Semiconductor ETFs
◐ List of Semiconductors ETFs
◐ List of Sharia ETFs
◐ List of Short Term Duration Bond ETFs
◐ List of Silver Miners ETFs
◐ List of Silver ETFs
◐ List of Small Cap Blend ETFs
◐ List of Small Cap Growth ETFs
◐ List of Small Cap Value ETFs
◐ List of Small Cap ETFs
◐ List of Socially Responsible ETFs
◐ List of Softs ETFs
◐ List of Software ETFs
◐ List of Solar Energy ETFs
◐ List of South Africa ETFs
◐ List of Spac ETFs
◐ List of Steel ETFs
◐ List of Technology ETFs
◐ List of Telecom ETFs
◐ List of Tips ETFs
◐ List of Transportation ETFs
◐ List of Treasury ETFs
◐ List of Trend Following ETFs
◐ List of Ultra Short Term Duration Bond ETFs
◐ List of Utilities ETFs
◐ List of Value ETFs
◐ List of Vix ETFs
◐ List of Volatility ETFs
◐ List of Water ETFs
◐ List of Zero Duration Bond ETFs